###begin article-title 0
Lamin A/C-mediated neuromuscular junction defects in Emery-Dreifuss muscular dystrophy
###end article-title 0
###begin p 1
###xml 31 52 31 52 <email xmlns:xlink="http://www.w3.org/1999/xlink">mistelit@mail.nih.gov</email>
Correspondence to Tom Misteli: mistelit@mail.nih.gov
###end p 1
###begin p 2
This article is distributed under the terms of an Attribution-Noncommercial-Share Alike-No Mirror Sites license for the first six months after the publication date (see ). After six months it is available under a Creative Commons License (Attribution-Noncommercial-Share Alike 3.0 Unported license, as described at ).
###end p 2
###begin p 3
###xml 4 8 4 8 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LMNA</italic>
###xml 159 163 159 163 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LMNA</italic>
###xml 369 373 369 373 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LMNA</italic>
###xml 817 821 817 821 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LMNA</italic>
###xml 191 196 <span type="species:ncbi:9606">human</span>
###xml 533 538 <span type="species:ncbi:10090">mouse</span>
###xml 803 811 <span type="species:ncbi:9606">patients</span>
###xml 878 883 <span type="species:ncbi:10090">mouse</span>
The LMNA gene encodes lamins A and C, two intermediate filament-type proteins that are important determinants of interphase nuclear architecture. Mutations in LMNA lead to a wide spectrum of human diseases including autosomal dominant Emery-Dreifuss muscular dystrophy (AD-EDMD), which affects skeletal and cardiac muscle. The cellular mechanisms by which mutations in LMNA cause disease have been elusive. Here, we demonstrate that defects in neuromuscular junctions (NMJs) are part of the disease mechanism in AD-EDMD. Two AD-EDMD mouse models show innervation defects including misexpression of electrical activity-dependent genes and altered epigenetic chromatin modifications. Synaptic nuclei are not properly recruited to the NMJ because of mislocalization of nuclear envelope components. AD-EDMD patients with LMNA mutations show the same cellular defects as the AD-EDMD mouse models. These results suggest that lamin A/C-mediated NMJ defects contribute to the AD-EDMD disease phenotype and provide insights into the cellular and molecular mechanisms for the muscle-specific phenotype of AD-EDMD.
###end p 3
###begin p 4
###xml 416 421 416 421 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hdac9</italic>
###xml 39 61 <span type="species:ncbi:272636">adeno-associated virus</span>
###xml 280 283 <span type="species:ncbi:12305?0.03296277145811789|species:ncbi:36410?3.8779731127197516E-4">CMV</span>
Abbreviations used in this paper: AAV, adeno-associated virus; AChR, acetylcholine receptor; AD-EDMD, autosomal dominant Emery-Dreifuss muscular dystrophy; ALS, amyotrophic lateral sclerosis; Bgt, bungarotoxin; BMD, Becker muscular dystrophy; CMS, congenital myasthenic syndrome; CMV, cytomegalovirus; DCM-CD, dilated cardiomyopathy and conduction system disease; FPLD, Dunnigan-type familial partial lipodystrophy; Hdac9, histone deacetylase 9; LAP2, lamina-associated polypeptide 2; LGMD1B, limb-girdle muscular dystrophy 1B; NMJ, neuromuscular junction; shRNA, short hairpin RNA.
###end p 4
###begin title 5
Introduction
###end title 5
###begin p 6
###xml 184 196 184 196 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib55">Wilson, 2000</xref>
###xml 198 221 198 221 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib7">Burke and Stewart, 2002</xref>
###xml 223 243 223 243 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib27">Mattout et al., 2006</xref>
###xml 250 254 250 254 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LMNA</italic>
###xml 474 494 474 494 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib34">Mounkes et al., 2003</xref>
###xml 496 519 496 519 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib8">Burke and Stewart, 2006</xref>
###xml 535 539 535 539 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LMNA</italic>
###xml 628 650 628 650 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib57">Worman and Bonne, 2007</xref>
###xml 1191 1210 1191 1210 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib6">Broers et al., 2006</xref>
###xml 1455 1473 1455 1473 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib16">Frock et al., 2006</xref>
###xml 1523 1542 1523 1542 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib5">Broers et al., 2004</xref>
###xml 1597 1615 1597 1615 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib3">Bakay et al., 2006</xref>
###xml 1673 1696 1673 1696 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib7">Burke and Stewart, 2002</xref>
###xml 1698 1718 1698 1718 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib27">Mattout et al., 2006</xref>
###xml 1331 1336 <span type="species:ncbi:9606">human</span>
The nuclear lamina is a thin filamentous protein layer beneath the nuclear envelope made up of A- and B-type lamins, which are members of the intermediate filament family of proteins (Wilson, 2000; Burke and Stewart, 2002; Mattout et al., 2006). The LMNA gene encodes the A-type lamins A and C. Both proteins are important determinants of interphase nuclear architecture and play essential roles in maintaining the integrity of the nuclear envelope and chromatin structure (Mounkes et al., 2003; Burke and Stewart, 2006). Mutations in LMNA have been associated with a wide range of diseases, commonly referred as laminopathies (Worman and Bonne, 2007). Despite the ubiquitous expression of A-type lamins, laminopathies are highly tissue-specific and typically affect one or few selected tissues, such as adipocytes in familial partial lipodystrophy of Dunnigan type (FPLD), nerve in Charcot-Marie-Tooth disorder type 2 (CMT2B), or cardiac muscle in dilated cardiomyopathy with conduction defects (DCM-CD). Two of the most common laminopathies are Emery-Dreifuss muscular dystrophy (AD-EDMD) and limb-girdle muscular dystrophy (LGMD), which both affect skeletal and cardiac striated muscles (Broers et al., 2006). The cellular and molecular mechanisms by which mutations in genes encoding ubiquitous nuclear envelope proteins cause human disease have been largely elusive. Several possible scenarios have been suggested including impaired differentiation (Frock et al., 2006), increased susceptibility to mechanical stress (Broers et al., 2004), lamin-mediated changes in gene expression programs (Bakay et al., 2006), and alterations in lamina-associated signaling events (Burke and Stewart, 2002; Mattout et al., 2006). Given the highly tissue-specific nature of laminopathies, it is possible that distinct mechanisms are responsible for defects in the various affected tissues.
###end p 6
###begin p 7
###xml 314 336 314 336 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib41">Schaeffer et al., 2001</xref>
###xml 338 356 338 356 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib28">Mejat et al., 2003</xref>
###xml 552 563 552 563 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib39">Ruegg, 2005</xref>
###xml 695 713 695 713 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib18">Grady et al., 2005</xref>
###xml 715 734 715 734 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib60">Zhang et al., 2007b</xref>
###xml 960 965 960 965 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SYNE1</italic>
###xml 970 975 970 975 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SYNE2</italic>
###xml 983 1001 983 1001 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib58">Zhang et al., 2001</xref>
###xml 1114 1131 1114 1131 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib1">Apel et al., 2000</xref>
###xml 1133 1151 1133 1151 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib18">Grady et al., 2005</xref>
###xml 1432 1451 1432 1451 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib44">Starr and Han, 2002</xref>
###xml 1453 1476 1453 1476 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib36">Padmakumar et al., 2005</xref>
###xml 1478 1496 1478 1496 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib10">Crisp et al., 2006</xref>
###xml 1498 1516 1498 1516 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib19">Haque et al., 2006</xref>
###xml 1658 1677 1658 1677 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib60">Zhang et al., 2007b</xref>
###xml 1565 1569 <span type="species:ncbi:10090">mice</span>
The skeletal muscle tissue is composed of multinucleated fibers formed by fusion of mononucleated cells during development. Among the hundreds of nuclei in a muscle fiber, approximately four to eight nuclei are specialized for the transcription of the components of the synapse at the neuromuscular junction (NMJ; Schaeffer et al., 2001; Mejat et al., 2003). These synaptic nuclei are recruited into the vicinity of the postsynaptic membrane during muscle differentiation, and their proper positioning is crucial for NMJ establishment and maintenance (Ruegg, 2005). Positioning of synaptic nuclei at the NMJ involves the interplay between the cytoskeleton and several nuclear envelope proteins (Grady et al., 2005; Zhang et al., 2007b), including Nesprin, also known as Syne for synaptic nuclear envelope, and SUN proteins. Nesprins are a very large family of outer or inner nuclear membrane transmembrane proteins encoded by extensively alternatively spliced SYNE1 and SYNE2 genes (Zhang et al., 2001), which anchor nuclei to the actin cytoskeleton via a pair of calponin homology (CH) domains at the N terminus (Apel et al., 2000; Grady et al., 2005). The luminal C-terminal KASH (klarsicht/ANC-1/syne) domain of Nesprin proteins interacts with SUN proteins, which span the inner nuclear membrane and physically interact with A-type lamins, establishing a continuous physical link between the nuclear lamina and the cytoskeleton (Starr and Han, 2002; Padmakumar et al., 2005; Crisp et al., 2006; Haque et al., 2006). Double knockout of Nesprin-1 and Nesprin-2 in mice leads to the complete absence of nuclei recruited to the synapses of diaphragm muscles (Zhang et al., 2007b), which demonstrates the importance of nuclear envelope components in synaptic nuclei positioning.
###end p 7
###begin p 8
###xml 275 286 275 286 <sup xmlns:xlink="http://www.w3.org/1999/xlink">H222P/H222P</sup>
###xml 271 286 271 286 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Lmna<sup>H222P/H222P</sup></italic>
###xml 295 298 295 298 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 291 298 291 298 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Lmna<sup>&#8722;/&#8722;</sup></italic>
###xml 651 662 651 662 <sup xmlns:xlink="http://www.w3.org/1999/xlink">H222P/H222P</sup>
###xml 647 662 647 662 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Lmna<sup>H222P/H222P</sup></italic>
###xml 671 674 671 674 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 667 674 667 674 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Lmna<sup>&#8722;/&#8722;</sup></italic>
###xml 299 303 <span type="species:ncbi:10090">mice</span>
###xml 338 343 <span type="species:ncbi:10090">mouse</span>
###xml 424 428 <span type="species:ncbi:10090">mice</span>
###xml 844 852 <span type="species:ncbi:9606">patients</span>
###xml 905 910 <span type="species:ncbi:9606">human</span>
We hypothesized that A-type lamins might contribute to the proper positioning of synaptic nuclei at the NMJ in muscle fibers, and, hence, we sought to test the possibility that A-type lamins-mediated NMJ defects contribute to AD-EDMD disease symptoms. Here, we show that LmnaH222P/H222P and Lmna-/- mice, two previously described AD-EDMD mouse models, fail to innervate muscle and exhibit aberrant NMJ architecture. In both mice models, several nuclear envelope components crucial for proper recruitment and positioning of synaptic nuclei are mislocalized, leading to a reduction in their number and their mispositioning at the NMJ. Consequently, LmnaH222P/H222P and Lmna-/- muscles show misexpression of electrical activity-dependent genes and altered epigenetic chromatin modifications. The same defects were present in biopsies from AD-EDMD patients, which indicates that these defects are relevant to human disease. The sum of our results suggests that failed muscle innervation contributes to AD-EDMD.
###end p 8
###begin title 9
Results
###end title 9
###begin title 10
###xml 38 43 <span type="species:ncbi:10090">mouse</span>
Muscle innervation defects in AD-EDMD mouse models
###end title 10
###begin p 11
###xml 117 120 117 120 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 113 120 113 120 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Lmna<sup>&#8722;/&#8722;</sup></italic>
###xml 129 140 129 140 <sup xmlns:xlink="http://www.w3.org/1999/xlink">H222P/H222P</sup>
###xml 125 140 125 140 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Lmna<sup>H222P/H222P</sup></italic>
###xml 164 168 164 168 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Lmna</italic>
###xml 274 295 274 295 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib47">Sullivan et al., 1999</xref>
###xml 325 358 325 358 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib11">De Sandre-Giovannoli et al., 2002</xref>
###xml 365 376 365 376 <sup xmlns:xlink="http://www.w3.org/1999/xlink">H222P/H222P</sup>
###xml 361 376 361 376 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Lmna<sup>H222P/H222P</sup></italic>
###xml 465 485 465 485 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib2">Arimura et al., 2005</xref>
###xml 762 782 762 782 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib2">Arimura et al., 2005</xref>
###xml 141 145 <span type="species:ncbi:10090">mice</span>
###xml 147 151 <span type="species:ncbi:10090">Mice</span>
###xml 377 381 <span type="species:ncbi:10090">mice</span>
###xml 516 520 <span type="species:ncbi:10090">mice</span>
###xml 569 577 <span type="species:ncbi:9606">patients</span>
To test whether AD-EDMD pathology involves muscle-nerve interaction defects, we analyzed innervation patterns in Lmna-/- and LmnaH222P/H222P mice. Mice lacking the Lmna gene die 6-7 wk after birth because of severe muscular dystrophy and cardiomyopathy, resembling AD-EDMD (Sullivan et al., 1999), and present an axonopathy (De Sandre-Giovannoli et al., 2002). LmnaH222P/H222P mice carry a missense mutation that was originally identified in a family with AD-EDMD (Arimura et al., 2005). Adult H222P homozygous male mice exhibit several symptoms reminiscent of AD-EDMD patients including reduced locomotion with abnormal stiff walking posture, cardiac fibrosis, chamber dilatation, and hypokinesia with conduction defects, and they typically die by 9 mo of age (Arimura et al., 2005).
###end p 11
###begin p 12
###xml 294 313 294 313 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig1" ref-type="fig">Fig. 1, A, C, and E</xref>
###xml 466 474 466 474 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig1" ref-type="fig">Fig. 1 A</xref>
###xml 511 522 511 522 <sup xmlns:xlink="http://www.w3.org/1999/xlink">H222P/H222P</sup>
###xml 507 522 507 522 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Lmna<sup>H222P/H222P</sup></italic>
###xml 531 534 531 534 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 527 534 527 534 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Lmna<sup>&#8722;/&#8722;</sup></italic>
###xml 692 707 692 707 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig1" ref-type="fig">Fig. 1, C and E</xref>
###xml 963 974 945 956 <sup xmlns:xlink="http://www.w3.org/1999/xlink">H222P/H222P</sup>
###xml 959 974 941 956 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Lmna<sup>H222P/H222P</sup></italic>
###xml 1075 1078 1054 1057 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 1071 1078 1050 1057 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Lmna<sup>&#8722;/&#8722;</sup></italic>
###xml 1115 1123 1091 1099 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig1" ref-type="fig">Fig. 1 I</xref>
###xml 1284 1303 1260 1279 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig1" ref-type="fig">Fig. 1, B, D, and F</xref>
###xml 1483 1494 1459 1470 <sup xmlns:xlink="http://www.w3.org/1999/xlink">H222P/H222P</sup>
###xml 1479 1494 1455 1470 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Lmna<sup>H222P/H222P</sup></italic>
###xml 1503 1506 1479 1482 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 1499 1506 1475 1482 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Lmna<sup>&#8722;/&#8722;</sup></italic>
###xml 1668 1686 1644 1662 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig1" ref-type="fig">Fig. 1 B, D, and F</xref>
###xml 1733 1736 1709 1712 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 1729 1736 1705 1712 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Lmna<sup>&#8722;/&#8722;</sup></italic>
###xml 1833 1848 1809 1824 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig1" ref-type="fig">Fig. 1, G and H</xref>
###xml 1968 1971 1944 1947 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 1964 1971 1940 1947 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Lmna<sup>&#8722;/&#8722;</sup></italic>
###xml 1980 1991 1956 1967 <sup xmlns:xlink="http://www.w3.org/1999/xlink">H222P/H222P</sup>
###xml 1976 1991 1952 1967 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Lmna<sup>H222P/H222P</sup></italic>
###xml 1079 1083 <span type="species:ncbi:10090">mice</span>
###xml 1270 1275 <span type="species:ncbi:10090">mouse</span>
When compared with wild-type littermates of identical genetic background, we found innervation defects in both animal models in the diaphragm visualized by staining for bungarotoxin (Bgt), which specifically binds to the acetylcholine receptors (AChR) accumulated at the muscle motor synapses (Fig. 1, A, C, and E). In wild-type animals, synapses are concentrated in a narrow band, and AChR clusters appear as a thin line in the middle of each hemidiaphragm muscle (Fig. 1 A). In contrast, in diaphragms of LmnaH222P/H222P and Lmna-/- animals, neuromuscular synapses are present outside of the central narrow end-plate band region, and synapses are scattered over a wider area of the muscle (Fig. 1, C and E). Quantitative analysis demonstrated that although the innervation area is limited to an approximately1-mm-wide band in wild-type animals (990 +/- 281 mum and 1,027 +/- 283 mum at 6 wk and 6 mo, respectively), it extends by an additional 40% in adult LmnaH222P/H222P (1,387 +/- 418 mum; P < 0.001) and by 70% in the phenotypically more severely affected 6-wk-old Lmna-/- mice (1,775 +/- 580 mum; P < 0.001; Fig. 1 I). In addition to the size of the postsynaptic innervation area, the branching pattern of the diaphragm's motor nerve was also affected in AD-EDMD mouse models (Fig. 1, B, D, and F). In contrast to wild-type animals where phrenic nerves, visualized by double-staining for neurofilament 150 kD and synaptophysin, showed few ramifications, phrenic nerves in LmnaH222P/H222P and Lmna-/- animals were highly branched and extended to a large area from the center of the diaphragm, with some ramifications covering the whole surface of the diaphragm (Fig. 1 B, D, and F, arrowhead). Compared with the wild type, Lmna-/- diaphragms showed intense nerve sprouting from both the main nerve axis and secondary branches (Fig. 1, G and H). The substantially altered innervation pattern pointed to a failure of motor nerves to innervate muscle fibers in Lmna-/- and LmnaH222P/H222P muscle fibers.
###end p 12
###begin p 13
###xml 0 59 0 59 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Innervation patterns in wild-type and AD-EDMD mouse models.</bold>
###xml 129 140 129 140 <sup xmlns:xlink="http://www.w3.org/1999/xlink">H222P/H222P</sup>
###xml 125 140 125 140 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Lmna<sup>H222P/H222P</sup></italic>
###xml 169 172 169 172 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 165 172 165 172 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Lmna<sup>&#8722;/&#8722;</sup></italic>
###xml 412 423 412 423 <sup xmlns:xlink="http://www.w3.org/1999/xlink">H222P/H222P</sup>
###xml 408 423 408 423 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Lmna<sup>H222P/H222P</sup></italic>
###xml 432 435 432 435 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 428 435 428 435 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Lmna<sup>&#8722;/&#8722;</sup></italic>
###xml 772 775 772 775 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 768 775 768 775 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Lmna<sup>&#8722;/&#8722;</sup></italic>
###xml 46 51 <span type="species:ncbi:10090">mouse</span>
###xml 183 187 <span type="species:ncbi:10090">mice</span>
###xml 940 944 <span type="species:ncbi:10090">mice</span>
###xml 1005 1009 <span type="species:ncbi:10090">mice</span>
Innervation patterns in wild-type and AD-EDMD mouse models. Whole-mount diaphragms of 6-mo-old wild-type (A and B), 6-mo-old LmnaH222P/H222P (C and D), and 6-wk-old Lmna-/- (E and F) mice were stained with Bgt to delineate the NMJs (AChR; A, C, and E), and neurofilament p150 and synaptophysin were used to stain the motor axon (B, D, and F). A representative right hemidiaphragm of each phenotype is shown. LmnaH222P/H222P and Lmna-/- diaphragms showed markedly broader synapse bands (A, C, and E) and highly ramified phrenic nerves (B, D, and F). (G and H) Enlargements of indicated areas (boxes in B and F) double-stained with neurofilament/synaptophysin (red) and Bgt (green) showing intense nerve sprouting from both the main nerve axis and secondary branches in Lmna-/- diaphragm (arrowheads). (I) Quantitation of postsynaptic innervation area width. Values shown are mean +/- SD of at least 200 measurements per diaphragm from three mice per genotype. *, P < 0.001 relative to wild-type littermate mice. Bars, 500 mum.
###end p 13
###begin title 14
###xml 35 40 <span type="species:ncbi:10090">mouse</span>
Abnormal NMJ morphology in AD-EDMD mouse models
###end title 14
###begin p 15
###xml 170 181 170 181 <sup xmlns:xlink="http://www.w3.org/1999/xlink">H222P/H222P</sup>
###xml 166 181 166 181 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Lmna<sup>H222P/H222P</sup></italic>
###xml 191 194 191 194 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 187 194 187 194 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Lmna<sup>&#8722;/&#8722;</sup></italic>
###xml 241 247 241 247 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig2" ref-type="fig">Fig. 2</xref>
###xml 339 347 339 347 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig2" ref-type="fig">Fig. 2 A</xref>
###xml 387 398 387 398 <sup xmlns:xlink="http://www.w3.org/1999/xlink">H222P/H222P</sup>
###xml 383 398 383 398 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Lmna<sup>H222P/H222P</sup></italic>
###xml 407 410 407 410 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 403 410 403 410 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Lmna<sup>&#8722;/&#8722;</sup></italic>
###xml 493 504 493 504 <sup xmlns:xlink="http://www.w3.org/1999/xlink">H222P/H222P</sup>
###xml 489 504 489 504 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Lmna<sup>H222P/H222P</sup></italic>
###xml 620 628 620 628 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig2" ref-type="fig">Fig. 2 B</xref>
###xml 692 695 692 695 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 688 695 688 695 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Lmna<sup>&#8722;/&#8722;</sup></italic>
###xml 836 844 836 844 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig2" ref-type="fig">Fig. 2 C</xref>
###xml 951 959 951 959 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig2" ref-type="fig">Fig. 2 D</xref>
###xml 1036 1039 1034 1037 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 1032 1039 1030 1037 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Lmna<sup>&#8722;/&#8722;</sup></italic>
###xml 1106 1117 1102 1113 <sup xmlns:xlink="http://www.w3.org/1999/xlink">H222P/H222P</sup>
###xml 1102 1117 1098 1113 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Lmna<sup>H222P/H222P</sup></italic>
###xml 1163 1183 1159 1179 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib2">Arimura et al., 2005</xref>
###xml 1287 1298 1271 1282 <sup xmlns:xlink="http://www.w3.org/1999/xlink">H222P/H222P</sup>
###xml 1283 1298 1267 1282 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Lmna<sup>H222P/H222P</sup></italic>
###xml 86 91 <span type="species:ncbi:10090">mouse</span>
###xml 1040 1044 <span type="species:ncbi:10090">mice</span>
###xml 1118 1122 <span type="species:ncbi:10090">mice</span>
###xml 1299 1303 <span type="species:ncbi:10090">mice</span>
To assess whether the structure of individual muscle synapses was affected in AD-EDMD mouse models, we compared the NMJ morphology in isolated fibers from wild-type, LmnaH222P/H222P, and Lmna-/- tibialis anterior muscles using Bgt staining (Fig. 2). In NMJs from wild-type muscle, AChR clusters form a typical continuous branched network (Fig. 2 A). Compared with wild-type animals, LmnaH222P/H222P and Lmna-/- synapses were markedly altered. The AChR network was usually discontinuous in LmnaH222P/H222P muscle, and several independent AChR clusters were frequently observed, which suggests a fragmentation of the NMJ (Fig. 2 B). Even more pronounced defects were present in muscle from Lmna-/- animals, where AChR networks were often dramatically disorganized, with fewer discernable individual branches and aggregated AChR clusters (Fig. 2 C). These observations were confirmed by quantitative analysis based on Bgt staining and AChR organization (Fig. 2 D). About 86.7 +/- 4.3% of synapses showed altered morphology in 6-wk-old Lmna-/- mice, and 72.3 +/- 2.6% of synapses were abnormal in 6-mo-old LmnaH222P/H222P mice, which showed slightly milder symptoms (Arimura et al., 2005). Importantly, a significant fraction of approximately50% of NMJs was already abnormal in 6-wk-old LmnaH222P/H222P mice, which do not yet show apparent muscle and locomotion defects. These data point to the possibility that NMJ disorganization takes place before the overt myopathic phenotype.
###end p 15
###begin p 16
###xml 0 64 0 64 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Abnormal NMJs in muscle from wild-type and AD-EDMD mouse models.</bold>
###xml 127 138 127 138 <sup xmlns:xlink="http://www.w3.org/1999/xlink">H222P/H222P</sup>
###xml 123 138 123 138 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Lmna<sup>H222P/H222P</sup></italic>
###xml 148 151 148 151 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 144 151 144 151 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Lmna<sup>&#8722;/&#8722;</sup></italic>
###xml 438 449 438 449 <sup xmlns:xlink="http://www.w3.org/1999/xlink">H222P/H222P</sup>
###xml 434 449 434 449 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Lmna<sup>H222P/H222P</sup></italic>
###xml 595 598 595 598 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 591 598 591 598 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Lmna<sup>&#8722;/&#8722;</sup></italic>
###xml 869 880 869 880 <sup xmlns:xlink="http://www.w3.org/1999/xlink">H222P/H222P</sup>
###xml 865 880 865 880 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Lmna<sup>H222P/H222P</sup></italic>
###xml 890 893 890 893 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 886 893 886 893 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Lmna<sup>&#8722;/&#8722;</sup></italic>
###xml 51 56 <span type="species:ncbi:10090">mouse</span>
###xml 152 156 <span type="species:ncbi:10090">mice</span>
###xml 260 264 <span type="species:ncbi:10090">mice</span>
###xml 894 898 <span type="species:ncbi:10090">mice</span>
Abnormal NMJs in muscle from wild-type and AD-EDMD mouse models. (A-C) Representative synapse morphologies from wild-type, LmnaH222P/H222P, and Lmna-/- mice isolated fibers from tibialis anterior stained with DAPI and Bgt. (A) Synapses from 6-mo-old wild-type mice showed characteristic "pretzel-like" AChR networks, and between four and eight nuclei directly aggregated beneath the NMJ (white arrowheads). (B) Synapses from 6-mo-old LmnaH222P/H222P were frequently fragmented with muscle nuclei located at the periphery of the AChR network (yellow arrowhead). (C) AChR staining in 6-wk-old Lmna-/- muscles was generally dramatically disorganized, with barely discernable branches, whereas few to no nuclei were observed underneath or at the periphery (yellow arrowheads) of the NMJ. (D) The percentage of abnormal NMJs observed in 6-wk-old and 6-mo-old wild-type, LmnaH222P/H222P, and Lmna-/- mice muscles. Values are mean +/- SD of at least 100 NMJ from three different animals in each genotype. Bars, 10 mum.
###end p 16
###begin title 17
###xml 61 66 <span type="species:ncbi:10090">mouse</span>
Mislocalization of nuclear positioning components in AD-EDMD mouse muscle
###end title 17
###begin p 18
###xml 44 48 44 48 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Lmna</italic>
###xml 301 304 301 304 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 297 304 297 304 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Lmna<sup>&#8722;/&#8722;</sup></italic>
###xml 313 324 313 324 <sup xmlns:xlink="http://www.w3.org/1999/xlink">H222P/H222P</sup>
###xml 309 324 309 324 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Lmna<sup>H222P/H222P</sup></italic>
###xml 497 500 497 500 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 493 500 493 500 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Lmna<sup>&#8722;/&#8722;</sup></italic>
###xml 509 520 509 520 <sup xmlns:xlink="http://www.w3.org/1999/xlink">H222P/H222P</sup>
###xml 505 520 505 520 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Lmna<sup>H222P/H222P</sup></italic>
###xml 529 537 529 537 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig3" ref-type="fig">Fig. 3 A</xref>
###xml 662 671 662 671 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig3" ref-type="fig">Figs. 3 A</xref>
###xml 752 755 752 755 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 748 755 748 755 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Lmna<sup>&#8722;/&#8722;</sup></italic>
###xml 764 775 764 775 <sup xmlns:xlink="http://www.w3.org/1999/xlink">H222P/H222P</sup>
###xml 760 775 760 775 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Lmna<sup>H222P/H222P</sup></italic>
###xml 784 792 784 792 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig3" ref-type="fig">Fig. 3 A</xref>
###xml 1071 1074 1071 1074 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 1067 1074 1067 1074 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Lmna<sup>&#8722;/&#8722;</sup></italic>
###xml 964 969 <span type="species:ncbi:10090">mouse</span>
To address the molecular mechanism by which Lmna mutations lead to altered NMJ morphology, we probed the localization of several prominent lamin A/C-interacting proteins in synaptic nuclei. Lamin B1, all isoforms of the lamina-associated polypeptide 2 (LAP2), and SUN1 proteins were unaffected in Lmna-/- and LmnaH222P/H222P muscle (not depicted and Fig. S1 A, available at ). However, the distribution of the inner nuclear membrane protein SUN2 was dramatically altered in synaptic nuclei of Lmna-/- and LmnaH222P/H222P muscle (Fig. 3 A). Although the protein was evenly distributed and enriched in the nuclear envelope in synaptic nuclei of wild-type animals (Figs. 3 A and S1 A), SUN2 was frequently aggregated on one side of synaptic nuclei in Lmna-/- and LmnaH222P/H222P muscle (Fig. 3 A). Aberrant SUN2 staining was specific for synaptic nuclei, as its localization pattern was generally indistinguishable in extrasynaptic nuclei from the wild type and both mouse models (Fig. S1 B). Occasionally, SUN2 was found punctuated in extrasynaptic nuclei, but only in Lmna-/- highly atrophic fibers (Fig. S1 C).
###end p 18
###begin p 19
###xml 0 90 0 90 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Mislocalization of nuclear envelope components in synaptic nuclei of AD-EDMD mouse models.</bold>
###xml 152 163 152 163 <sup xmlns:xlink="http://www.w3.org/1999/xlink">H222P/H222P</sup>
###xml 148 163 148 163 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Lmna<sup>H222P/H222P</sup></italic>
###xml 182 185 182 185 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 178 185 178 185 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Lmna<sup>&#8722;/&#8722;</sup></italic>
###xml 650 661 650 661 <sup xmlns:xlink="http://www.w3.org/1999/xlink">H222P/H222P</sup>
###xml 646 661 646 661 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Lmna<sup>H222P/H222P</sup></italic>
###xml 670 673 670 673 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 666 673 666 673 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Lmna<sup>&#8722;/&#8722;</sup></italic>
###xml 77 82 <span type="species:ncbi:10090">mouse</span>
###xml 186 190 <span type="species:ncbi:10090">mice</span>
###xml 580 585 <span type="species:ncbi:10090">mouse</span>
Mislocalization of nuclear envelope components in synaptic nuclei of AD-EDMD mouse models. Isolated muscle fibers from 6-mo-old wild-type, 6-mo-old LmnaH222P/H222P, and 6-wk-old Lmna-/- mice tibialis anterior muscles were stained with DAPI, Bgt, and SUN2 (A) or Nesprin-1 antibodies (B). SUN2 and Nesprin-1 were expressed in all muscle nuclei but with a lower staining in mutant synaptic nuclei (A and B). Boxes indicate the area enlarged in the panel below. Compared with wild type, SUN2 appeared heterogeneous and frequently aggregated on one side of synaptic nuclei in AD-EDMD mouse models (A, white arrows). Nesprin-1 staining was reduced in LmnaH222P/H222P and Lmna-/- synaptic nuclei and partly relocalized (B). In all cases, Schwann cell nuclei (yellow arrowheads) were negative for both Nesprin-1 and SUN2. Bars, 10 mum.
###end p 19
###begin p 20
###xml 23 26 23 26 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 19 26 19 26 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Lmna<sup>&#8722;/&#8722;</sup></italic>
###xml 35 46 35 46 <sup xmlns:xlink="http://www.w3.org/1999/xlink">H222P/H222P</sup>
###xml 31 46 31 46 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Lmna<sup>H222P/H222P</sup></italic>
###xml 143 151 143 151 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig3" ref-type="fig">Fig. 3 B</xref>
###xml 354 362 354 362 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig3" ref-type="fig">Fig. 3 B</xref>
###xml 364 381 364 381 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib1">Apel et al., 2000</xref>
###xml 477 480 477 480 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 473 480 473 480 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Lmna<sup>&#8722;/&#8722;</sup></italic>
###xml 489 500 489 500 <sup xmlns:xlink="http://www.w3.org/1999/xlink">H222P/H222P</sup>
###xml 485 500 485 500 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Lmna<sup>H222P/H222P</sup></italic>
###xml 578 589 578 589 <sup xmlns:xlink="http://www.w3.org/1999/xlink">H222P/H222P</sup>
###xml 574 589 574 589 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Lmna<sup>H222P/H222P</sup></italic>
###xml 598 601 598 601 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 594 601 594 601 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Lmna<sup>&#8722;/&#8722;</sup></italic>
###xml 651 659 651 659 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig3" ref-type="fig">Fig. 3 B</xref>
###xml 47 51 <span type="species:ncbi:10090">mice</span>
Muscle nuclei from Lmna-/- and LmnaH222P/H222P mice also exhibited pronounced mislocalization of the outer nuclear envelope protein Nesprin-1 (Fig. 3 B). As previously reported, in wild-type muscle fibers, Nesprin-1 was expressed in all muscle nuclei and highly enriched at the synaptic nuclear envelope but was hardly detectable in Schwann cell nuclei (Fig. 3 B; Apel et al., 2000). Although Nesprin-1 localization and intensity was not altered in extrasynaptic nuclei of Lmna-/- and LmnaH222P/H222P muscle fibers (Fig. S1 B), perinuclear Nesprin-1 staining was reduced in LmnaH222P/H222P and Lmna-/- synaptic nuclei compared with wild-type animals (Fig. 3 B). Collectively, these observations demonstrate that the absence of A-type lamins or H222P mutation affects synaptic nuclear envelope organization but has little effect on localization of Nesprin-1 in extrasynaptic nuclei, which supports a role of A-type lamins in NMJ formation or maintenance.
###end p 20
###begin title 21
###xml 20 25 <span type="species:ncbi:10090">mouse</span>
Muscle from AD-EDMD mouse models fails to recruit synaptic nuclei
###end title 21
###begin p 22
###xml 101 119 101 119 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib19">Haque et al., 2006</xref>
###xml 121 147 121 147 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib56">Worman and Gundersen, 2006</xref>
###xml 421 429 421 429 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig4" ref-type="fig">Fig. 4 A</xref>
###xml 477 488 477 488 <sup xmlns:xlink="http://www.w3.org/1999/xlink">H222P/H222P</sup>
###xml 473 488 473 488 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Lmna<sup>H222P/H222P</sup></italic>
###xml 497 500 497 500 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 493 500 493 500 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Lmna<sup>&#8722;/&#8722;</sup></italic>
###xml 707 715 707 715 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig4" ref-type="fig">Fig. 4 A</xref>
###xml 717 735 717 735 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib18">Grady et al., 2005</xref>
###xml 832 840 832 840 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig4" ref-type="fig">Fig. 4 A</xref>
###xml 842 860 842 860 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib18">Grady et al., 2005</xref>
###xml 1053 1067 1051 1065 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig4" ref-type="fig">Fig. 4 B and C</xref>
###xml 1089 1092 1087 1090 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 1085 1092 1083 1090 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Lmna<sup>&#8722;/&#8722;</sup></italic>
###xml 1307 1315 1303 1311 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig4" ref-type="fig">Fig. 4 D</xref>
###xml 1390 1393 1386 1389 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 1386 1393 1382 1389 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Lmna<sup>&#8722;/&#8722;</sup></italic>
###xml 285 290 <span type="species:ncbi:10090">mouse</span>
###xml 690 705 <span type="species:ncbi:10090">transgenic mice</span>
SUN and Nesprin have been implicated in positioning nuclei via their interaction with A-type lamins (Haque et al., 2006; Worman and Gundersen, 2006). Given the aberrant localization of SUN2 and Nesprin-1, we tested whether the localization of nuclei to the NMJ was affected in AD-EDMD mouse models. Normal NMJs are characterized by tight clustering of several muscle nuclei directly underneath the postsynaptic membrane (Fig. 4 A). Compared with NMJs in wild-type animals, LmnaH222P/H222P and Lmna-/- synapses showed less muscle nuclei, most of them being located at the immediate synapse periphery in a pattern similar to that of aberrantly localized nuclei in dominant-negative Nesprin-1 transgenic mice (Fig. 4 A; Grady et al., 2005). Quantitation of the number of synaptic and perisynaptic nuclei defined by Nesprin-1 staining (Fig. 4 A; Grady et al., 2005) demonstrated that although in 6-wk-old wild-type muscle, 4.5 +/- 0.76 muscle nuclei are found aggregated beneath the AChR clusters and almost no nuclei were found in a perisynaptic position (Fig. 4 B and C), in age-matched Lmna-/- synapses, only 1.3 +/- 0.8 nuclei were at the synapse, and typically, approximately two nuclei were found in a perisynaptic position. Consistent with these observations, quantification of total nuclei per synapse (Fig. 4 D) showed a global decrease in the number of muscle nuclei recruited to Lmna-/- synapses (3.1 +/- 0.9 nuclei per synapse) compared with wild-type synapses (4.8 +/- 0.6 nuclei per synapse), which suggests that in the absence of functional A-type lamins, both positioning and recruitment of synaptic nuclei are affected.
###end p 22
###begin p 23
###xml 0 50 0 50 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Altered recruitment of the muscle synaptic nuclei.</bold>
###xml 469 480 468 479 <sup xmlns:xlink="http://www.w3.org/1999/xlink">H222P/H222P</sup>
###xml 465 480 464 479 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Lmna<sup>H222P/H222P</sup></italic>
###xml 499 502 498 501 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 495 502 494 501 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Lmna<sup>&#8722;/&#8722;</sup></italic>
###xml 503 507 <span type="species:ncbi:10090">mice</span>
Altered recruitment of the muscle synaptic nuclei. (A) Isolated muscle fibers were stained with DAPI, Bgt, and Nesprin-1 antibodies to unequivocally identify synaptic myonuclei (yellow arrowheads). Bars, 10 mum. (B-D) Nesprin-1-positive myonuclei were quantified according to their relative position to the Bgt staining. Percentage of synaptic (B), perisynaptic (C), and total (D) nuclei per muscle synapse of 6-wk-old and 6-mo-old wild-type, 6-wk-old and 6-mo-old LmnaH222P/H222P, and 6-wk-old Lmna-/- mice are shown. Values are mean +/- SD of at least 100 NMJs from three different animals in each genotype. *, P < 0.001 relative to littermate wild type.
###end p 23
###begin p 24
###xml 73 84 73 84 <sup xmlns:xlink="http://www.w3.org/1999/xlink">H222P/H222P</sup>
###xml 69 84 69 84 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Lmna<sup>H222P/H222P</sup></italic>
###xml 442 453 434 445 <sup xmlns:xlink="http://www.w3.org/1999/xlink">H222P/H222P</sup>
###xml 438 453 430 445 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Lmna<sup>H222P/H222P</sup></italic>
###xml 727 738 715 726 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig4" ref-type="fig">Fig. 4, B&#8211;D</xref>
###xml 821 825 809 813 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Lmna</italic>
###xml 917 922 <span type="species:ncbi:10090">mouse</span>
In line with their milder muscular phenotype, synapses from 6-mo-old LmnaH222P/H222P showed a significant, albeit less dramatic, reduction in the number of muscle nuclei recruited to the synapse sites (2.5 +/- 0.9 synaptic nuclei per synapse and 3.2 +/- 0.9 total nuclei per synapse) compared with 6-mo-old wild-type muscles (4.3 +/- 1.0 synaptic nuclei per synapse and 4.6 +/- 0.9 total nuclei per synapse). Interestingly, at 6 wk, when LmnaH222P/H222P animals are still asymptomatic, synapses already had a reduced number of nuclei (2.9 +/- 1.0 synaptic nuclei; 3.7 +/- 0.9 total nuclei per synapse) compared with wild-type littermate animals, which further supports the notion that NMJ defects occur before muscle symptoms (Fig. 4, B-D). From these observations, we concluded that the absence of A-type lamins or some Lmna mutations contribute to failed recruitment and positioning of nuclei at the NMJ in AD-EDMD mouse models.
###end p 24
###begin title 25
###xml 50 55 <span type="species:ncbi:10090">mouse</span>
Functional consequences of NMJ defects in AD-EDMD mouse models
###end title 25
###begin p 26
###xml 74 85 74 85 <sup xmlns:xlink="http://www.w3.org/1999/xlink">H222P/H222P</sup>
###xml 70 85 70 85 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Lmna<sup>H222P/H222P</sup></italic>
###xml 94 97 94 97 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 90 97 90 97 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Lmna<sup>&#8722;/&#8722;</sup></italic>
###xml 225 236 225 236 <sup xmlns:xlink="http://www.w3.org/1999/xlink">H222P/H222P</sup>
###xml 221 236 221 236 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Lmna<sup>H222P/H222P</sup></italic>
###xml 246 249 246 249 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 242 249 242 249 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Lmna<sup>&#8722;/&#8722;</sup></italic>
###xml 258 266 258 266 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig5" ref-type="fig">Fig. 5 A</xref>
###xml 289 294 285 290 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Chrng</italic>
###xml 395 417 391 413 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib41">Schaeffer et al., 2001</xref>
###xml 419 437 415 433 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib28">Mejat et al., 2003</xref>
###xml 540 545 536 541 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Chrng</italic>
###xml 570 593 566 589 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib9">Chevessier et al., 2004</xref>
###xml 595 613 591 609 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib29">Mejat et al., 2005</xref>
###xml 627 632 623 628 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Chrng</italic>
###xml 718 729 714 725 <sup xmlns:xlink="http://www.w3.org/1999/xlink">H222P/H222P</sup>
###xml 714 729 710 725 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Lmna<sup>H222P/H222P</sup></italic>
###xml 747 750 743 746 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 743 750 739 746 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Lmna<sup>&#8722;/&#8722;</sup></italic>
###xml 803 811 799 807 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig5" ref-type="fig">Fig. 5 A</xref>
###xml 900 905 892 897 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Chrna</italic>
###xml 982 1004 974 996 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib41">Schaeffer et al., 2001</xref>
###xml 1006 1024 998 1016 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib28">Mejat et al., 2003</xref>
###xml 1119 1124 1111 1116 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Chrna</italic>
###xml 1126 1146 1118 1138 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib13">Duclert et al., 1991</xref>
###xml 1148 1167 1140 1159 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib31">Merlie et al., 1994</xref>
###xml 1204 1207 1196 1199 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 1200 1207 1192 1199 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Lmna<sup>&#8722;/&#8722;</sup></italic>
###xml 1216 1227 1208 1219 <sup xmlns:xlink="http://www.w3.org/1999/xlink">H222P/H222P</sup>
###xml 1212 1227 1204 1219 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Lmna<sup>H222P/H222P</sup></italic>
###xml 1249 1254 1241 1246 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Chrna</italic>
###xml 1316 1324 1308 1316 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig5" ref-type="fig">Fig. 5 A</xref>
###xml 1378 1383 1370 1375 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Myod1</italic>
###xml 1399 1403 1391 1395 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Myog</italic>
###xml 1548 1567 1540 1559 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib31">Merlie et al., 1994</xref>
###xml 1621 1632 1613 1624 <sup xmlns:xlink="http://www.w3.org/1999/xlink">H222P/H222P</sup>
###xml 1617 1632 1609 1624 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Lmna<sup>H222P/H222P</sup></italic>
###xml 1641 1644 1633 1636 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 1637 1644 1629 1636 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Lmna<sup>&#8722;/&#8722;</sup></italic>
###xml 1654 1662 1646 1654 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig5" ref-type="fig">Fig. 5 A</xref>
###xml 1688 1693 1680 1685 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hdac9</italic>
###xml 1711 1716 1703 1708 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Myod1</italic>
###xml 1721 1725 1713 1717 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Myog</italic>
###xml 1771 1789 1763 1781 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib29">Mejat et al., 2005</xref>
###xml 1826 1829 1818 1821 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 1822 1829 1814 1821 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Lmna<sup>&#8722;/&#8722;</sup></italic>
###xml 1838 1849 1830 1841 <sup xmlns:xlink="http://www.w3.org/1999/xlink">H222P/H222P</sup>
###xml 1834 1849 1826 1841 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Lmna<sup>H222P/H222P</sup></italic>
###xml 1923 1941 1915 1933 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib29">Mejat et al., 2005</xref>
###xml 1989 1995 1981 1987 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Fbxo32</italic>
###xml 2053 2071 2045 2063 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib17">Gomes et al., 2001</xref>
###xml 2073 2092 2065 2084 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib40">Sandri et al., 2004</xref>
###xml 2138 2141 2130 2133 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 2134 2141 2126 2133 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Lmna<sup>&#8722;/&#8722;</sup></italic>
###xml 2150 2161 2142 2153 <sup xmlns:xlink="http://www.w3.org/1999/xlink">H222P/H222P</sup>
###xml 2146 2161 2138 2153 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Lmna<sup>H222P/H222P</sup></italic>
###xml 2184 2192 2176 2184 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig5" ref-type="fig">Fig. 5 A</xref>
###xml 2245 2250 2231 2236 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Chrne</italic>
###xml 2310 2330 2296 2316 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib13">Duclert et al., 1991</xref>
###xml 2355 2358 2341 2344 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 2351 2358 2337 2344 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Lmna<sup>&#8722;/&#8722;</sup></italic>
###xml 2367 2378 2353 2364 <sup xmlns:xlink="http://www.w3.org/1999/xlink">H222P/H222P</sup>
###xml 2363 2378 2349 2364 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Lmna<sup>H222P/H222P</sup></italic>
###xml 2423 2426 2409 2412 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 2419 2426 2405 2412 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Lmna<sup>&#8722;/&#8722;</sup></italic>
###xml 2435 2446 2421 2432 <sup xmlns:xlink="http://www.w3.org/1999/xlink">H222P/H222P</sup>
###xml 2431 2446 2417 2432 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Lmna<sup>H222P/H222P</sup></italic>
###xml 98 102 <span type="species:ncbi:10090">mice</span>
###xml 751 755 <span type="species:ncbi:10090">mice</span>
To assess the functional consequences of morphological NMJ defects in LmnaH222P/H222P and Lmna-/- mice, we probed gene expression levels of several electrical activity-dependent genes by quantitative RT-PCR in wild-type, LmnaH222P/H222P, and Lmna-/- muscle (Fig. 5 A). AChR-gamma subunit (Chrng) expression is normally restricted to embryonic development and is repressed by muscle innervation (Schaeffer et al., 2001; Mejat et al., 2003), but pathological inefficient neurotransmission or experimental denervation leads to reexpression of Chrng in adult muscle fibers (Chevessier et al., 2004; Mejat et al., 2005). Similarly, Chrng levels were significantly up-regulated by 8- and 14-fold in muscle from 6-mo-old LmnaH222P/H222P and 6-wk-old Lmna-/- mice, respectively, compared with wild-type muscle (Fig. 5 A). Likewise, muscle innervation normally represses expression of the AChR-alpha subunit (Chrna) in extrasynaptic myonuclei, restricting its expression to synaptic nuclei (Schaeffer et al., 2001; Mejat et al., 2003). In inefficient neurotransmission and experimental denervation, nonsynaptic nuclei reexpress Chrna (Duclert et al., 1991; Merlie et al., 1994). Similar to denervated muscle, Lmna-/- and LmnaH222P/H222P muscle overexpressed Chrna 2.7- and 2.2-fold compared with littermate wild-type muscle (Fig. 5 A). Furthermore, the myogenic regulatory factors MyoD (Myod1) and myogenin (Myog), which are down-regulated in adult innervated muscle fiber and reexpressed in inefficient neurotransmission and upon experimental denervation (Merlie et al., 1994), were up-regulated between 2.5- and 6.1-fold in LmnaH222P/H222P and Lmna-/- muscles (Fig. 5 A). Histone deacetylase 9 (Hdac9), which controls Myod1 and Myog in an electrical activity-dependent fashion (Mejat et al., 2005), was down-regulated twofold in Lmna-/- and LmnaH222P/H222P muscle, similar to what is observed in experimentally denervated muscle (Mejat et al., 2005). Finally, as in denervated muscle, atrogin-1 (Fbxo32), a strong marker of denervation-induced muscle atrophy (Gomes et al., 2001; Sandri et al., 2004), was overexpressed 2.7- and 2.9-fold in Lmna-/- and LmnaH222P/H222P muscle, respectively (Fig. 5 A). As a control, the levels of AChR-epsilon subunit (Chrne), which is known to be independent of electrical activity (Duclert et al., 1991), were unchanged in Lmna-/- and LmnaH222P/H222P muscle (not depicted). We conclude that Lmna-/- and LmnaH222P/H222P muscle gene expression patterns are highly similar to those observed in denervated muscle.
###end p 26
###begin p 27
###xml 0 49 0 49 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Hallmarks of denervation in AD-EDMD mouse models.</bold>
###xml 80 85 80 85 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Chrng</italic>
###xml 87 92 87 92 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Chrna</italic>
###xml 94 98 94 98 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Myog</italic>
###xml 100 105 100 105 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MyoD1</italic>
###xml 107 113 107 113 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Fbxo32</italic>
###xml 119 124 119 124 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hdac9</italic>
###xml 158 169 158 169 <sup xmlns:xlink="http://www.w3.org/1999/xlink">H222P/H222P</sup>
###xml 154 169 154 169 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Lmna<sup>H222P/H222P</sup></italic>
###xml 179 182 179 182 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 175 182 175 182 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Lmna<sup>&#8722;/&#8722;</sup></italic>
###xml 325 330 325 330 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Chrng</italic>
###xml 332 337 332 337 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Chrna</italic>
###xml 339 343 339 343 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Myog</italic>
###xml 349 354 349 354 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MyoD1</italic>
###xml 386 392 386 392 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Fbxo32</italic>
###xml 438 443 438 443 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hdac9</italic>
###xml 510 515 510 515 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gapdh</italic>
###xml 768 772 766 770 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Lmna</italic>
###xml 953 964 951 962 <sup xmlns:xlink="http://www.w3.org/1999/xlink">H222P/H222P</sup>
###xml 949 964 947 962 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Lmna<sup>H222P/H222P</sup></italic>
###xml 973 976 971 974 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 969 976 967 974 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Lmna<sup>&#8722;/&#8722;</sup></italic>
###xml 36 41 <span type="species:ncbi:10090">mouse</span>
###xml 183 187 <span type="species:ncbi:10090">mice</span>
###xml 581 585 <span type="species:ncbi:10090">mice</span>
###xml 1201 1205 <span type="species:ncbi:10090">mice</span>
Hallmarks of denervation in AD-EDMD mouse models. (A) mRNA expression levels of Chrng, Chrna, Myog, MyoD1, Fbxo32, and Hdac9 were evaluated in wild-type, LmnaH222P/H222P, and Lmna-/- mice gastrocnemius muscles by quantitative RT-PCR (A). Mutant muscles showed higher expression levels of electrical activity-dependent genes (Chrng, Chrna, Myog, and MyoD1) and atrophy-associated genes (Fbxo32). In contrast, mutant muscles expressed less Hdac9 than the wild type. All gene expression levels were normalized to Gapdh. Values are mean +/- SD from six muscles (two muscles from three mice) per genotype. *, P < 0.001 relative to the wild type. Expression levels in each sample were evaluated in at least two independent quantitative RT-PCR experiments. (B) Wild-type and Lmna mutant isolated muscle fibers from tibialis anterior muscle were stained with DAPI, Bgt, and acetylated histone H3-K9 or acetylated histone H4 antibodies. A high proportion of LmnaH222P/H222P and Lmna-/- fibers displayed increased histone acetylation levels. The percentage of histone hyperacetylated muscle fibers are indicated for the different genotypes. Values are means +/- SD from at least 100 fibers from three different mice per genotype. Bars, 25 mum.
###end p 27
###begin p 28
###xml 106 111 106 111 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hdac9</italic>
###xml 129 147 129 147 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib29">Mejat et al., 2005</xref>
###xml 277 280 277 280 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 273 280 273 280 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Lmna<sup>&#8722;/&#8722;</sup></italic>
###xml 290 301 290 301 <sup xmlns:xlink="http://www.w3.org/1999/xlink">H222P/H222P</sup>
###xml 286 301 286 301 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Lmna<sup>H222P/H222P</sup></italic>
###xml 448 474 448 474 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib37">Ravel-Chapuis et al., 2007</xref>
###xml 747 750 747 750 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 743 750 743 750 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Lmna<sup>&#8722;/&#8722;</sup></italic>
###xml 759 770 759 770 <sup xmlns:xlink="http://www.w3.org/1999/xlink">H222P/H222P</sup>
###xml 755 770 755 770 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Lmna<sup>H222P/H222P</sup></italic>
###xml 800 808 800 808 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig5" ref-type="fig">Fig. 5 B</xref>
###xml 1063 1071 1063 1071 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig5" ref-type="fig">Fig. 5 B</xref>
###xml 1157 1165 1157 1165 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig5" ref-type="fig">Fig. 5 C</xref>
###xml 1251 1254 1251 1254 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 1247 1254 1247 1254 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Lmna<sup>&#8722;/&#8722;</sup></italic>
###xml 1340 1351 1328 1339 <sup xmlns:xlink="http://www.w3.org/1999/xlink">H222P/H222P</sup>
###xml 1336 1351 1324 1339 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Lmna<sup>H222P/H222P</sup></italic>
###xml 1420 1431 1408 1419 <sup xmlns:xlink="http://www.w3.org/1999/xlink">H222P/H222P</sup>
###xml 1416 1431 1404 1419 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Lmna<sup>H222P/H222P</sup></italic>
###xml 1487 1495 1463 1471 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig5" ref-type="fig">Fig. 5 C</xref>
###xml 1601 1607 1577 1583 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig2" ref-type="fig">Fig. 2</xref>
###xml 1255 1259 <span type="species:ncbi:10090">mice</span>
###xml 1352 1356 <span type="species:ncbi:10090">mice</span>
###xml 1432 1436 <span type="species:ncbi:10090">mice</span>
###xml 1481 1485 <span type="species:ncbi:10090">mice</span>
###xml 1595 1599 <span type="species:ncbi:10090">mice</span>
A further hallmark of denervated muscle is an increase in histone acetylation, likely as a consequence of Hdac9 down-regulation (Mejat et al., 2005). To assess whether global chromatin modifications are also present in the two animal models, we stained isolated wild-type, Lmna-/-, and LmnaH222P/H222P muscle fibers using antibodies against acetylated histone H3 lysine 9 (H3-AcK9) or pan-acetylated histone H4 (panAc-H4). As described previously (Ravel-Chapuis et al., 2007), we observed elevated H3-K9 and pan-H4 acetylation in synaptic nuclei compared with extrasynaptic nuclei in wild-type muscle fibers (Fig. S2, available at ). However, compared with wild-type muscle, histones H3-K9 and H4 acetylation levels were strongly increased in Lmna-/- and LmnaH222P/H222P muscle extrasynaptic nuclei (Fig. 5 B) and were comparable in synaptic nuclei (Fig. S2). To verify that this extrasynaptic nuclei histone hyperacetylation was related to a defect in neuromuscular transmission, we quantified the number of hyperacetylated fibers in each type of mutant muscle (Fig. 5 B). We found that the percentage of hyperacetylated fibers accompanies muscle defects (Fig. 5 C). More than 90% of fibers were globally hyperacetylated in the severely affected Lmna-/- mice, approximately70% were hyperacetylated in the more mildly affected 6-mo-old LmnaH222P/H222P mice, and 40% were hyperacetylated in the asymptomatic 6-wk-old LmnaH222P/H222P mice, compared with approximately7% in wild-type mice (Fig. 5 C). These numbers are also similar to the percentage of abnormal NMJs in the three groups of AD-EDMD mice (Fig. 2).
###end p 28
###begin title 29
Transient A-type lamin knockdown in wild-type tibialis anterior recapitulates NMJ defects
###end title 29
###begin p 30
To confirm that the observed NMJ defects were a direct cause of A-type lamins loss and not caused by an indirect nerve defect, we knocked down A-type lamins in tibialis anterior muscle of wild-type animals using adeno-associated viruses (AAV) expressing short hairpin RNAs (shRNAs) against LMNA. In pilot experiments to optimize viral transduction, injection of AAV6-GFP virus into muscle resulted in expression of the GFP transgene in >90% of muscle cells 1 wk after transduction; expression was limited to muscle and was absent from Schwann cells and neurons (Fig. S3 A, available at ). Injection of AAV6 expressing shRNA against A-type lamins (AAV6-shLMNA) in tibialis anterior muscle, but presumably not in adjacent neurons, resulted in an approximately70% decrease of A-type lamin protein levels 2 wk after injection, and was maintained 5 wk after injection (Fig. S3 B). No decrease in A-type lamin mRNA or protein levels occurred in the noninjected tibialis interior control muscle over the same time period in the same animal injected with AAV6 expressing shRNA against GFP (AAV6-shGFP; Fig. S3 B).
###end p 30
###begin p 31
###xml 369 377 369 377 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig6" ref-type="fig">Fig. 6 A</xref>
###xml 590 598 578 586 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig6" ref-type="fig">Fig. 6 A</xref>
###xml 891 899 879 887 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig6" ref-type="fig">Fig. 6 B</xref>
###xml 1089 1097 1077 1085 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig6" ref-type="fig">Fig. 6 B</xref>
###xml 1605 1620 1581 1596 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig6" ref-type="fig">Fig. 6, C and D</xref>
###xml 110 115 <span type="species:ncbi:10090">mouse</span>
###xml 630 635 <span type="species:ncbi:10090">mouse</span>
###xml 1127 1132 <span type="species:ncbi:10090">mouse</span>
Knockdown of A-type lamins in muscle from wild-type animals recapitulated the NMJ defects observed in AD-EDMD mouse models. After 3 wk, we observed a significant increase in the number of fragmented NMJs in tibialis anterior muscles injected with AAV6-shLMNA, whereas AAV6-shGFP-injected control muscles only showed a slight variation compared with noninjected muscle (Fig. 6 A). 4 and 5 wk after injection, approximately60% of the NMJs showed an altered morphology in AAV6-shLMNA-injected muscle, whereas in AAV6-shGFP and in noninjected control muscle, only 10-15% of NMJs were abnormal (Fig. 6 A). Similarly, as in the AD-EDMD mouse models, SUN2 proteins were frequently mislocalized and aggregated in synaptic nuclei of tibialis anterior muscle injected with AAV6-shLMNA, whereas SUN2 staining was homogeneous and indistinguishable from wild-type animals in AAV6-shGFP-injected muscles (Fig. 6 B). Interestingly, SUN2 localization was frequently found altered in NMJs, which still showed normal AChR organization, suggesting that SUN2 reorganization precedes NMJ architecture defects (Fig. 6 B). As observed in the AD-EDMD mouse models, SUN2 staining was not affected in extrasynaptic nuclei of AAV6-shLMNA-injected muscles (not depicted). Finally, the number of hyperacetylated muscle fibers (histones H4 and H3-K9) strictly correlated with the proportion of abnormal NMJs in injected tibialis anterior muscles and reached approximately60% in AAV6-shLMNA-injected tibialis anterior muscles 4 wk after injection, but was only slightly higher in AAV6-shGFP-injected muscles than in noninjected muscle (Fig. 6, C and D). Collectively, these results demonstrate that the observed NMJ defects are directly mediated by A-type lamins and that their loss in the muscle, but not in the nerve itself, is sufficient to cause AD-EDMD symptoms.
###end p 31
###begin p 32
###xml 0 64 0 64 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Transient A-type lamin knockdown in wild-type tibialis anterior.</bold>
###xml 146 150 146 150 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LMNA</italic>
###xml 270 281 270 281 <sup xmlns:xlink="http://www.w3.org/1999/xlink">H222P/H222P</sup>
###xml 266 281 266 281 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Lmna<sup>H222P/H222P</sup></italic>
###xml 290 293 290 293 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 286 293 286 293 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Lmna<sup>&#8722;/&#8722;</sup></italic>
###xml 827 831 <span type="species:ncbi:10090">mice</span>
Transient A-type lamin knockdown in wild-type tibialis anterior. Wild-type tibialis anterior muscles injected with AAV6 expressing shRNAs against LMNA (shLMNA) or GFP (shGFP) were assessed at the indicated time after AAV injection for several phenotypes observed in LmnaH222P/H222P and Lmna-/- muscles: NMJ morphology (A), SUN2 localization (B), and H3 and H4 histone acetylation levels (C and D). For each assay, a representative NMJ or muscle fiber from shLMNA- or shGFP-injected muscle 4 wk after injection is provided with the quantification of the number of altered NMJ per fiber at each time point. Hyperacetylated nuclei visible on shGFP (C) correspond to nuclei from nonmuscle interstitial cells and were used as positive controls for the staining. Values are means +/- SD from at least 100 fibers from three different mice per criteria.
###end p 32
###begin title 33
###xml 33 41 <span type="species:ncbi:9606">patients</span>
Denervation hallmarks in AD-EDMD patients
###end title 33
###begin p 34
###xml 453 458 453 458 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CHRNG</italic>
###xml 460 465 460 465 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CHRNA</italic>
###xml 471 475 471 475 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MYOG</italic>
###xml 504 510 504 510 <italic xmlns:xlink="http://www.w3.org/1999/xlink">FBXO32</italic>
###xml 614 618 614 618 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LMNA</italic>
###xml 663 671 663 671 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig7" ref-type="fig">Fig. 7 A</xref>
###xml 1064 1076 1064 1076 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib26">Matsuo, 1996</xref>
###xml 1078 1101 1078 1101 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib9">Chevessier et al., 2004</xref>
###xml 1103 1130 1103 1130 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib43">Shelley and Colquhoun, 2005</xref>
###xml 1132 1158 1132 1158 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib32">Mitchell and Borasio, 2007</xref>
###xml 1566 1574 1566 1574 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig7" ref-type="fig">Fig. 7 B</xref>
###xml 1700 1708 1700 1708 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig7" ref-type="fig">Fig. 7 B</xref>
###xml 65 70 <span type="species:ncbi:10090">mouse</span>
###xml 95 100 <span type="species:ncbi:9606">human</span>
###xml 109 117 <span type="species:ncbi:9606">patients</span>
###xml 231 236 <span type="species:ncbi:9606">human</span>
###xml 319 324 <span type="species:ncbi:9606">human</span>
###xml 542 549 <span type="species:ncbi:9606">patient</span>
###xml 794 802 <span type="species:ncbi:9606">patients</span>
###xml 1198 1206 <span type="species:ncbi:9606">patients</span>
###xml 1281 1289 <span type="species:ncbi:9606">patients</span>
###xml 1331 1339 <span type="species:ncbi:9606">patients</span>
To finally assess whether the NMJ defects we observed in AD-EDMD mouse models also occurred in human AD-EDMD patients, histological features, gene expression of denervation markers, and global histone acetylation were evaluated in human muscles biopsies. Morphological innervation and NMJ defects cannot be assessed in human samples because of the scarcity of NMJs in muscle biopsies. Histology and expression of the electrical activity-dependent genes CHRNG, CHRNA, and MYOG and the muscle atrophy gene FBXO32 were evaluated in five AD-EDMD patient biopsies representing five different characterized mutations in LMNA affecting different domains in the protein (Fig. 7 A and Table S1, available at ); these were compared with normal volunteer biopsies (Table S1). As further controls, we used patients affected by the established denervation syndrome amyotrophic lateral sclerosis (ALS) and the NMJ disease congenital myasthenic syndrome (CMS); and as a negative control, we used biopsies from Becker muscular dystrophy (BMD), which does not involve denervation (Matsuo, 1996; Chevessier et al., 2004; Shelley and Colquhoun, 2005; Mitchell and Borasio, 2007). Histologically, muscles from AD-EDMD patients showed morphological features of denervated muscle similar to ALS and CMS patients and distinct from BMD. As in ALS and CMS patients, AD-EDMD muscles were characterized by large variations in fiber diameter, numerous angular atrophic fibers, or round hypotrophic fibers as well as few centrally located nuclei, most nuclei being in a subsarcolemmal position (Fig. 7 B). In contrast, BMD muscles showed a majority of large centronucleated fibers typical of cycles of necrosis and regeneration (Fig. 7 B).
###end p 34
###begin p 35
###xml 0 43 0 43 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Hallmarks of denervation in human patients.</bold>
###xml 925 930 920 925 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CHRNG</italic>
###xml 932 937 927 932 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CHRNA</italic>
###xml 939 943 934 938 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MYOG</italic>
###xml 945 950 940 945 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MYOD1</italic>
###xml 1250 1255 1245 1250 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CHRNG</italic>
###xml 1257 1262 1252 1257 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CHRNA</italic>
###xml 1264 1268 1259 1263 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MYOG</italic>
###xml 1274 1280 1269 1275 <italic xmlns:xlink="http://www.w3.org/1999/xlink">FBXO32</italic>
###xml 1521 1526 1516 1521 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CHRNG</italic>
###xml 1528 1533 1523 1528 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CHRNA</italic>
###xml 1539 1543 1534 1538 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MYOG</italic>
###xml 1650 1655 1645 1650 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MYOD1</italic>
###xml 1907 1912 1902 1907 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GAPDH</italic>
###xml 28 33 <span type="species:ncbi:9606">human</span>
###xml 34 42 <span type="species:ncbi:9606">patients</span>
###xml 240 248 <span type="species:ncbi:9606">patients</span>
###xml 858 866 <span type="species:ncbi:9606">patients</span>
###xml 1004 1009 <span type="species:ncbi:9606">human</span>
###xml 1020 1028 <span type="species:ncbi:9606">Patients</span>
###xml 1068 1076 <span type="species:ncbi:9606">patients</span>
###xml 1156 1164 <span type="species:ncbi:9606">patients</span>
###xml 1316 1324 <span type="species:ncbi:9606">patients</span>
###xml 1396 1404 <span type="species:ncbi:9606">Patients</span>
###xml 1549 1557 <span type="species:ncbi:9606">patients</span>
###xml 1956 1963 <span type="species:ncbi:9606">patient</span>
###xml 2074 2082 <span type="species:ncbi:9606">patients</span>
Hallmarks of denervation in human patients. (A) Schematic representation of A-type lamin proteins. The position of the different mutations studied is indicated along the length of the protein. (B) Muscle biopsies from AD-EDMD, BMD, and CMS patients as well as normal volunteer (NV) were stained with DAPI (blue), alpha2-laminin antibody (green), and acetylated-histone H3-lysine 9 (K9) antibody (red). Atrophic muscle fibers (asterisks) showed a very high level of acetylation and no grouping of atrophic fibers. Muscle fibers of normal size occasionally showed hyperacetylated nuclei in AD-EDMD muscles. In contrast, hyperacetylated nuclei were only observed in nonmuscle interstitial cells in NV muscles. Although many centrally located nuclei could be observed in BMD muscles (arrowheads), most nuclei were in a subsarcolemmal position in AD-EDMD and CMS patients and in NV muscles. Bars, 30 mum. (C) Expression levels of CHRNG, CHRNA, MYOG, MYOD1, and FBXO32 were evaluated by quantitative RT-PCR on human biopsies. Patients affected by AD-EDMD were compared with patients affected by LGMD1B, FLPD-DCM-CD, ALS, CMS, BMD, and NV. Compared with NV, EDMD patients showed high, though similar to denervation-related diseases (ALS and CMS), levels of CHRNG, CHRNA, MYOG, and FBXO32. In contrast, expression levels of patients affected by the nondenervation-related disease BMD were similar to NV. Patients affected by other laminopathies (LGMD1B and FPLD-DCM-CD) showed low, though similar to normal volunteers, levels of CHRNG, CHRNA, and MYOG. All patients affected by neuromuscular diseases (ALS, CMS, EDMD, LGMD1B, and BMD) showed a high level of MYOD1 compared with NV but this could be caused by two independent mechanisms: misregulation in the muscle fibers (ALS, CMS, and potentially EDMD) and/or regeneration by the activated satellite cells (BMD). All gene expression levels were normalized to the GAPDH expression level. Values provided for each patient are means +/- SD from at least three independent experiments. Broken lines indicate mean values of a group of patients.
###end p 35
###begin p 36
###xml 234 242 234 242 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig7" ref-type="fig">Fig. 7 C</xref>
###xml 245 250 245 250 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CHRNG</italic>
###xml 252 257 252 257 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CHRNA</italic>
###xml 259 263 259 263 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MYOG</italic>
###xml 265 270 265 270 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MYOD1</italic>
###xml 276 282 276 282 <italic xmlns:xlink="http://www.w3.org/1999/xlink">FBXO32</italic>
###xml 366 374 366 374 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig7" ref-type="fig">Fig. 7 C</xref>
###xml 669 677 669 677 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig7" ref-type="fig">Fig. 7 C</xref>
###xml 701 706 701 706 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MYOD1</italic>
###xml 816 838 816 838 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib4">Bhagavati et al., 1996</xref>
###xml 854 859 854 859 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CHRNG</italic>
###xml 861 866 861 866 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CHRNA</italic>
###xml 868 872 868 872 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MYOG</italic>
###xml 878 884 878 884 <italic xmlns:xlink="http://www.w3.org/1999/xlink">FBXO32</italic>
###xml 1056 1081 1056 1081 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib49">van der Kooi et al., 2002</xref>
###xml 1153 1168 1153 1168 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig7" ref-type="fig">Fig. 7, A and C</xref>
###xml 73 78 <span type="species:ncbi:10090">mouse</span>
###xml 99 107 <span type="species:ncbi:9606">patients</span>
###xml 417 425 <span type="species:ncbi:9606">patients</span>
###xml 558 566 <span type="species:ncbi:9606">patients</span>
###xml 944 952 <span type="species:ncbi:9606">patients</span>
###xml 1003 1010 <span type="species:ncbi:9606">patient</span>
With regards to gene expression, similar to what was observed in AD-EDMD mouse models, all AD-EDMD patients showed gene expression profiles distinct from normal controls and were more similar to the denervation syndromes ALS and CMS (Fig. 7 C). CHRNG, CHRNA, MYOG, MYOD1, and FBXO32 expression levels were all significantly elevated compared with normal volunteers (Fig. 7 C) and were often even higher than those in patients affected by the innervation-related diseases ALS and CMS. Importantly, expression levels of these genes were distinct from those of patients affected by BMD, which showed expression levels of these genes close or similar to normal volunteers (Fig. 7 C). The up-regulation of MYOD1 in BMD is likely due to the activation of satellite cells and extensive muscle regeneration in this disease (Bhagavati et al., 1996). In contrast, CHRNG, CHRNA, MYOG, and FBXO32 expression levels were low and similar to normal levels in patients with LGMD1B, a striated muscle laminopathy, and a patient affected by a FPLD with DCM-CD (FPLD-DCM-CD; van der Kooi et al., 2002), a laminopathy in which the fat tissue and heart muscle are affected (Fig. 7, A and C). This points to the fact that there is no innervation defect in these laminopathies and that denervation is not a general feature of muscular dystrophies or striated muscle laminopathies.
###end p 36
###begin p 37
###xml 242 250 242 250 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig7" ref-type="fig">Fig. 7 B</xref>
###xml 482 490 482 490 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig7" ref-type="fig">Fig. 7 B</xref>
###xml 594 602 594 602 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig7" ref-type="fig">Fig. 7 B</xref>
###xml 60 68 <span type="species:ncbi:9606">patients</span>
###xml 101 106 <span type="species:ncbi:10090">mouse</span>
###xml 584 592 <span type="species:ncbi:9606">patients</span>
###xml 764 772 <span type="species:ncbi:9606">patients</span>
Consistent with functional denervation of muscle in AD-EDMD patients and our observations in AD-EDMD mouse models, nuclei from atrophic AD-EDMD muscle fibers also showed high levels of H3-K9 histone acetylation compared with normal controls (Fig. 7 B, asterisks). Importantly, increased histone acetylation was also observed in muscle fibers that did not show any physiological signs of atrophy, which suggests that the histone hyperacetylation is an early event preceding atrophy (Fig. 7 B, arrowheads). Similar patterns were also observed in muscles from ALS (not depicted) and CMS patients (Fig. 7 B) or using acetylated histone H4 antibody (not depicted). Collectively, these results support the presence of innervation defects in skeletal muscle from AD-EDMD patients.
###end p 37
###begin title 38
Discussion
###end title 38
###begin p 39
###xml 542 546 542 546 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LMNA</italic>
###xml 201 206 <span type="species:ncbi:10090">mouse</span>
###xml 314 319 <span type="species:ncbi:10090">mouse</span>
###xml 528 536 <span type="species:ncbi:9606">patients</span>
###xml 715 720 <span type="species:ncbi:10090">mouse</span>
We have investigated here the molecular mechanisms by which mutations in the nuclear architectural proteins lamin A and C give rise to muscular dystrophy. We demonstrate that muscle in two established mouse models of EDMD exhibit altered innervation patterns and abnormal NMJ morphology. As a consequence, AD-EDMD mouse models show signs of innervation defects including misexpression of electrical activity-dependent genes and altered epigenetic chromatin modifications. The same molecular defects occur in muscle from AD-EDMD patients with LMNA mutations. At the molecular level, we show that several nuclear envelope proteins involved in proper positioning of nuclei near the synapse are mislocalized in AD-EDMD mouse models, and recruitment of synaptic nuclei is impaired. These results provide insights into the cellular and molecular mechanisms for the muscle-specific phenotype of AD-EDMD, and they strongly suggest that NMJ defects contribute to the AD-EDMD disease phenotype.
###end p 39
###begin title 40
NMJ defects in AD-EDMD
###end title 40
###begin p 41
###xml 153 157 153 157 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Lmna</italic>
###xml 157 160 157 160 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 222 240 222 240 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib16">Frock et al., 2006</xref>
###xml 296 300 296 300 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Lmna</italic>
###xml 300 303 300 303 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 334 338 334 338 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Lmna</italic>
###xml 338 341 338 341 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 421 440 421 440 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib30">Melcon et al., 2006</xref>
The molecular basis of how mutations in A-type lamins lead to muscle dystrophy has been elusive. One model is based on the observation that immortalized Lmna-/- myoblasts are impaired in their differentiation to myotubes (Frock et al., 2006); however, in vivo regeneration of cardiotoxin-treated Lmna-/- muscles is normal and primary Lmna-/- myoblast cultures do not show impairment in their differentiation to myotubes (Melcon et al., 2006).
###end p 41
###begin p 42
###xml 560 564 560 564 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Lmna</italic>
###xml 756 780 756 780 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib33">Mittelbronn et al., 2006</xref>
###xml 1264 1268 1264 1268 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LMNA</italic>
###xml 161 166 <span type="species:ncbi:10090">mouse</span>
###xml 417 422 <span type="species:ncbi:10090">mouse</span>
###xml 433 440 <span type="species:ncbi:9606">patient</span>
###xml 808 816 <span type="species:ncbi:9606">patients</span>
###xml 892 900 <span type="species:ncbi:9606">patients</span>
###xml 950 955 <span type="species:ncbi:10090">mouse</span>
###xml 975 983 <span type="species:ncbi:9606">patients</span>
We provide several lines of evidence for a model involving NMJ defects in AD-EDMD. First, innervation patterns and NMJ morphology are altered in two independent mouse models of AD-EDMD. Second, synaptic nuclei fail to be recruited to the NMJ in the animal models. Third, several electrical activity-dependent genes are misregulated, and denervation-characteristic histone modification patterns are present in AD-EDMD mouse model and patient samples, likely as a consequence of defective NMJ morphology. Furthermore, the proportion of altered NMJs in transient Lmna knockdown muscles strictly correlated with the number of histone hyperacetylated fibers, a hallmark of functional denervation. Fourth, our histological observations confirm previous reports (Mittelbronn et al., 2006) that muscles from AD-EDMD patients show morphological features similar to denervated muscles from ALS and CMS patients but were distinct from BMD. Finally, we found in mouse models and AD-EDMD patients that the gene expression pattern of several electrical activity-dependent genes resembles that of ALS, an established muscle denervation syndrome, and CMS, an established altered NMJ syndrome, but is distinct from the expression profile of these genes in BMD as well as two other LMNA-related diseases not associated with innervation defects.
###end p 42
###begin p 43
###xml 317 321 317 321 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LMNA</italic>
###xml 448 467 448 467 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib50">Walter et al., 2005</xref>
###xml 699 716 699 716 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib21">Hong et al., 2005</xref>
###xml 718 742 718 742 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib33">Mittelbronn et al., 2006</xref>
###xml 820 841 820 841 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib45">Stevens et al., 1999a</xref>
###xml 842 843 842 843 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib46">b</xref>
###xml 992 1023 992 1023 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib38">Rowinska-Marcinska et al., 2005</xref>
###xml 204 211 <span type="species:ncbi:9606">patient</span>
###xml 499 507 <span type="species:ncbi:9606">patients</span>
###xml 896 904 <span type="species:ncbi:9606">patients</span>
###xml 1150 1155 <span type="species:ncbi:10090">mouse</span>
###xml 1167 1174 <span type="species:ncbi:9606">patient</span>
Our findings of altered innervation and abnormal NMJ architecture in AD-EDMD muscle based on morphological and gene expression analysis are in line with observations on the electrical activity of AD-EDMD patient muscle. Conventional and single-fiber electromyography in a family with a variant of AD-EDMD caused by a LMNA mutation revealed electromyographic alterations in motor unit potentials that were suggestive of neurogenic muscular changes (Walter et al., 2005). Moreover, muscle biopsies of patients with AD-EDMD showed a mild mixed myopathic and neurogenic pattern with scattered small-angular atrophic myofibers, marked atrophy of type 1 fibers, and a clear predominance of type 2 fibers (Hong et al., 2005; Mittelbronn et al., 2006), which is similar to the slow-to-fast fiber switch observed in denervation (Stevens et al., 1999a,b). In addition, atrophied muscle fibers from AD-EDMD patients do not appear grouped, a hallmark of atrophy caused by degeneration of the nerve cell (Rowinska-Marcinska et al., 2005). These physiological observations are consistent with the presence of the cellular and molecular defects observed in AD-EDMD mouse models and patient tissue reported here.
###end p 43
###begin p 44
###xml 358 369 358 369 <sup xmlns:xlink="http://www.w3.org/1999/xlink">H222P/H222P</sup>
###xml 354 369 354 369 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Lmna<sup>H222P/H222P</sup></italic>
###xml 432 452 432 452 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib2">Arimura et al., 2005</xref>
###xml 664 667 664 667 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 660 667 660 667 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Lmna<sup>&#8722;/&#8722;</sup></italic>
###xml 723 756 723 756 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib11">De Sandre-Giovannoli et al., 2002</xref>
###xml 1254 1258 1254 1258 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Lmna</italic>
###xml 1258 1261 1258 1261 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 1329 1362 1329 1362 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib11">De Sandre-Giovannoli et al., 2002</xref>
###xml 370 374 <span type="species:ncbi:10090">mice</span>
###xml 1262 1266 <span type="species:ncbi:10090">mice</span>
Our observations indicate that the abnormal innervation and NMJ defects are a cause and not a secondary consequence of altered, possibly chronic, muscle defects. This is supported by the fact that NMJ defects occur before any apparent muscle defects. We found altered innervation, failed synaptic nuclei recruitment, and SUN2 mislocalization in 6-wk-old LmnaH222P/H222P mice that are asymptomatic for muscle and locomotion defects (Arimura et al., 2005). In addition, all NMJ defects strongly correlate with the severity of symptoms in the animal models, and SUN2 aggregation occurred before NMJ alterations upon transient knockdown of A-type lamins. Although Lmna-/- animals exhibit axonal defects as previously reported (De Sandre-Giovannoli et al., 2002), the fact that transient knockdown of A-type lamins in muscle is sufficient to recapitulate the main phenotypes in the absence of nerve defects or muscle fibrosis indicates that loss of A-type lamins is causal for the NMJ phenotype. Because the AAV6 used here does not efficiently infect Schwann cells or the nerve, the NMJ defects must be caused by the impaired function of A-type lamins in the muscle and not the nerve. These results also suggest that the previously observed axonal defects in Lmna-/- mice are likely a consequence of loss of lamin function in muscle (De Sandre-Giovannoli et al., 2002). Based on these observations, we propose that the primary defect in muscular A-type lamin function leads to NMJ defects that ultimately contribute to the muscle atrophy observed in AD-EDMD.
###end p 44
###begin title 45
A-type lamins mediate positioning of synaptic nuclei
###end title 45
###begin p 46
###xml 1226 1230 1226 1230 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Lmna</italic>
###xml 1488 1491 1488 1491 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 1484 1491 1484 1491 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Lmna<sup>&#8722;/&#8722;</sup></italic>
###xml 1505 1525 1505 1525 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib24">Libotte et al., 2005</xref>
###xml 1664 1682 1664 1682 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib18">Grady et al., 2005</xref>
###xml 1885 1904 1885 1904 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib60">Zhang et al., 2007b</xref>
###xml 1203 1208 <span type="species:ncbi:10090">mouse</span>
###xml 1742 1746 <span type="species:ncbi:10090">mice</span>
Our data argue for a model in which A-type lamins play a structural role in organizing the molecular complexes responsible for the recruitment and positioning of synapse-associated nuclei underneath the postsynaptic membrane. In support, we show that the absence or mutation of A-type lamins causes mislocalization of two of the key components of the nuclear positioning machinery, the inner nuclear membrane protein SUN2 and the outer nuclear membrane component Nesprin-1, which links the nuclear envelope to the cytoskeleton. Strikingly, this mislocalization of SUN2 and Nesprin-1 was limited to synaptic nuclei but was not observed in extrasynaptic nuclei, which suggests a link between the organization of nuclear envelope components in synaptic nuclei and NMJ defects. We propose that as a consequence of this misorganization of the inner nuclear membrane, the number of muscle nuclei recruited at the synapse is reduced and the remaining synaptic nuclei beneath the NMJ tend to be progressively mislocalized or lost. This may lead to unstable NMJs, inefficient neurotransmission between the muscle and nerve, and innervation defects of the muscle fiber. Because the primary defect in both AD-EDMD mouse models is in the Lmna gene, these observations directly implicate A-type lamins and the SUN-Nesprin complex in the recruitment and positioning of synaptic nuclei. This interpretation is in line with earlier data demonstrating that Nesprin-1 and Nesprin-2 are mislocalized in Lmna-/- fibroblasts (Libotte et al., 2005), that overexpression of a dominant-negative form of Nesprin-1 induces relocalization of synaptic nuclei at the periphery of the synapse (Grady et al., 2005), and that complete knockout of Nesprin-1 and Nesprin-2 in mice affects viability with immediate death at birth because of the complete absence of nuclei recruited to the synapses of diaphragm muscles (Zhang et al., 2007b).
###end p 46
###begin p 47
###xml 182 201 182 201 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib20">Hodzic et al., 2004</xref>
###xml 203 226 203 226 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib36">Padmakumar et al., 2005</xref>
###xml 228 246 228 246 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib10">Crisp et al., 2006</xref>
###xml 248 266 248 266 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib19">Haque et al., 2006</xref>
###xml 321 325 321 325 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Lmna</italic>
###xml 334 338 334 338 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Lmna</italic>
###xml 950 973 950 973 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib36">Padmakumar et al., 2005</xref>
###xml 975 993 975 993 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib10">Crisp et al., 2006</xref>
###xml 995 1013 995 1013 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib19">Haque et al., 2006</xref>
###xml 1015 1032 1015 1032 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib51">Wang et al., 2006</xref>
###xml 1158 1175 1158 1175 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib12">Ding et al., 2007</xref>
###xml 1177 1193 1177 1193 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib25">Liu et al., 2007</xref>
###xml 1195 1215 1195 1215 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib42">Schmitt et al., 2007</xref>
It seems likely that A-type lamins act by organizing SUN proteins in the inner nuclear membrane, which then determines their interaction with Nesprins in the outer nuclear membrane (Hodzic et al., 2004; Padmakumar et al., 2005; Crisp et al., 2006; Haque et al., 2006). Interestingly, we find here differential effects of Lmna loss or Lmna mutations on SUN1 and SUN2. In synaptic nuclei, where SUN1 is expressed at low levels, SUN2 localization is dramatically affected by A-type lamins mutation or its absence; whereas, in extrasynaptic nuclei, where SUN1 is present, SUN2 localization is only slightly altered, suggesting that SUN1 might compensate for A-type lamins defects. Our findings point to the fact that, in muscle, SUN1 localization to the nuclear envelope is not dependent on A-type lamins, whereas SUN2 localization is, confirming biochemical studies showing that SUN1 and SUN2 localized to the nuclear envelope via different mechanisms (Padmakumar et al., 2005; Crisp et al., 2006; Haque et al., 2006; Wang et al., 2006). Our findings also confirm that SUN1 and SUN2 are not redundant and may play different roles in the inner nuclear membrane (Ding et al., 2007; Liu et al., 2007; Schmitt et al., 2007). Whether these interactions are primarily important for formation or maintenance of NMJs is not known.
###end p 47
###begin title 48
Implications for candidate AD-EDMD genes
###end title 48
###begin p 49
###xml 111 115 111 115 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LMNA</italic>
###xml 129 132 129 132 <italic xmlns:xlink="http://www.w3.org/1999/xlink">EMD</italic>
###xml 186 205 186 205 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib59">Zhang et al., 2007a</xref>
###xml 408 413 408 413 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SYNE1</italic>
###xml 418 423 418 423 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SYNE2</italic>
###xml 461 480 461 480 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib59">Zhang et al., 2007a</xref>
###xml 718 738 711 731 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib54">Wheeler et al., 2007</xref>
###xml 840 844 826 830 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LMNA</italic>
###xml 867 887 853 873 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib22">Kandert et al., 2007</xref>
###xml 1057 1061 1043 1047 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SUN1</italic>
###xml 1114 1118 1100 1104 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SUN1</italic>
###xml 1207 1224 1193 1210 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib12">Ding et al., 2007</xref>
###xml 1365 1369 1351 1355 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SUN2</italic>
###xml 1410 1415 1396 1401 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SYNE1</italic>
###xml 1603 1607 1589 1593 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SUN2</italic>
###xml 176 184 <span type="species:ncbi:9606">patients</span>
###xml 427 435 <span type="species:ncbi:9606">patients</span>
###xml 1094 1102 <span type="species:ncbi:9606">patients</span>
###xml 1129 1133 <span type="species:ncbi:10090">mice</span>
###xml 1477 1482 <span type="species:ncbi:10090">mouse</span>
###xml 1681 1689 <span type="species:ncbi:9606">patients</span>
Our observations have implications for identification of additional AD-EDMD genes. Mutations in A-type lamins (LMNA) and emerin (EMD) currently only account for 50% of AD-EDMD patients (Zhang et al., 2007a). Our findings indicate that components involved in synaptic nuclei positioning are potential AD-EDMD candidate genes. This possibility has recently been validated by the identification of mutations in SYNE1 and SYNE2 in patients with AD-EDMD phenotypes (Zhang et al., 2007a). Moreover, Nesprin-1alpha and Nesprin-2beta interactions with the nuclear envelope have been shown to be disrupted in X-linked EDMD cells, which suggests that emerin might also play a role in the synaptic nuclear envelope organization (Wheeler et al., 2007). Finally, Nesprin-2, emerin, LAP2alpha, and LAP2beta localization has been shown to be disturbed in LMNA S143F progeria cells (Kandert et al., 2007), which suggests that the interaction between lamins and Nesprins may not only play a role in muscular laminopathies. In agreement with our data, so far no mutations in SUN1 have been identified in AD-EDMD patients. Moreover, SUN1-deficient mice develop normally into adults without any evidence of muscular dystrophy (Ding et al., 2007), indicating that, at least in the presence of A-type lamins, SUN1 is dispensable during muscle development. However, here we show that the SUN2 expression pattern is highly similar to SYNE1 and that its localization is dramatically altered in AD-EDMD mouse model synaptic nuclei, which suggests it may be a crucial component of the synaptic nuclei envelope. For these reasons, SUN2 represents a novel gene candidate to be screened for mutation in AD-EDMD patients.
###end p 49
###begin title 50
Tissue specificity of AD-EDMD
###end title 50
###begin p 51
###xml 450 454 450 454 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LMNA</italic>
###xml 568 579 568 579 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib14">Ellis, 2006</xref>
###xml 970 987 970 987 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib1">Apel et al., 2000</xref>
###xml 989 1005 989 1005 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib48">Sun et al., 2002</xref>
###xml 1117 1133 1117 1133 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib48">Sun et al., 2002</xref>
###xml 1755 1766 1755 1766 <sup xmlns:xlink="http://www.w3.org/1999/xlink">H222P/H222P</sup>
###xml 1751 1766 1751 1766 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Lmna<sup>H222P/H222P</sup></italic>
###xml 1773 1791 1773 1791 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib28">Mejat et al., 2003</xref>
###xml 1793 1812 1793 1812 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib35">Muchir et al., 2007</xref>
###xml 616 620 <span type="species:ncbi:10090">mice</span>
###xml 1264 1272 <span type="species:ncbi:9606">patients</span>
###xml 1767 1771 <span type="species:ncbi:10090">mice</span>
One of the most intriguing aspects of laminopathies is the question of how mutations in the ubiquitously expressed A-type lamin proteins lead to tissue-restricted disorders. We find here that various subsets of muscle nuclei express distinct combinations of the lamin-interacting proteins SUN1 and SUN2, and that this expression pattern correlates with susceptibility to AD-EDMD mutations. It is therefore possible that the tissue-specific nature of LMNA mutations is caused by the presence of particular combinations of lamin-interacting proteins in various tissues (Ellis, 2006). We find that AD-EDMD mutations in mice primarily affect the synaptic nuclei in the context of the plurinucleated muscle. Interestingly, synaptic nuclei only express SUN2 and Nesprin-1, whereas extrasynaptic nuclei express SUN1, SUN2, and Nesprin-1. Strikingly, Nesprin-1 and SUN2 are preferentially expressed at high levels in skeletal muscle and heart, both tissues affected in AD-EDMD (Apel et al., 2000; Sun et al., 2002). Moreover, SUN2 has been identified as one of the genes differentially expressed in congenital heart defects (Sun et al., 2002), which suggests that SUN2, and maybe Nesprin-1, alteration might affect heart physiology. Obviously, the cardiac defects in EDMD patients are not mediated through NMJ defects because cardiac muscle lacks NMJ. A possibility is that mutations in lamin A not only affect the nuclear envelope but also, via the SUN-Nesprin axis, the cytoskeleton, and possibly even the plasma membrane, as indicated by our finding of altered AChR organization at the cell surface. Interestingly, the ERK1/2-MAP kinase pathways whose upstream receptors are at the plasma membrane have recently been shown to be up-regulated in heart from LmnaH222P/H222P mice (Mejat et al., 2003; Muchir et al., 2007).
###end p 51
###begin p 52
###xml 613 618 <span type="species:ncbi:9606">human</span>
Collectively, our data suggest a mechanistic model for the laminopathy AD-EDMD. We propose that AD-EDMD mutations alter the structural organization of the nuclear envelope in synaptic nuclei of muscle fibers. As a result, the SUN-Nesprin-mediated interaction of the nucleus with the cytoskeleton is interrupted, leading to failed recruitment and mispositioning of synapse-associated myonuclei. Lamin A/C-mediated neurotransmission defects may result in the misregulation of electrical activity-dependent genes and to global chromatin rearrangements. These results strongly indicate that NMJ defects contribute to human AD-EDMD, and they provide insights into the cellular and molecular disease mechanism of a laminopathy.
###end p 52
###begin title 53
Materials and methods
###end title 53
###begin title 54
Animals
###end title 54
###begin p 55
###xml 0 4 0 4 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Lmna</italic>
###xml 11 15 11 15 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Lmna</italic>
###xml 15 18 15 18 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+</sup>
###xml 20 24 20 24 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Lmna</italic>
###xml 24 27 24 27 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/&#8722;</sup>
###xml 33 37 33 37 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Lmna</italic>
###xml 37 40 37 40 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 50 61 50 61 <sup xmlns:xlink="http://www.w3.org/1999/xlink">H222P/H222P</sup>
###xml 46 61 46 61 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Lmna<sup>H222P/H222P</sup></italic>
###xml 63 83 63 83 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib2">Arimura et al., 2005</xref>
###xml 85 106 85 106 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib47">Sullivan et al., 1999</xref>
###xml 5 9 <span type="species:ncbi:10090">mice</span>
###xml 151 156 <span type="species:ncbi:10090">mouse</span>
###xml 422 426 <span type="species:ncbi:10090">mice</span>
###xml 541 545 <span type="species:ncbi:10090">mice</span>
Lmna mice (Lmna+/+, Lmna+/-, and Lmna-/-) and LmnaH222P/H222P (Arimura et al., 2005; Sullivan et al., 1999) were housed individually and provided with mouse chow and water ad libitum in restricted-access, specific-pathogen-free animal care facilities at the National Institutes of Health (Bethesda, MD) and the Institute of Myology (Paris, France), respectively. To avoid any influence from the genetic background, mutant mice were always compared with their wild-type littermates. All experimental procedures were performed on C57BL/6 male mice according to National Institutes of Health Animal Care Protocol approved by the National Cancer Institute Center for Cancer Research Animal Care and Use Committee.
###end p 55
###begin title 56
###xml 0 5 <span type="species:ncbi:9606">Human</span>
Human samples
###end title 56
###begin p 57
###xml 0 7 <span type="species:ncbi:9606">Patient</span>
###xml 146 154 <span type="species:ncbi:9606">Children</span>
###xml 576 583 <span type="species:ncbi:9606">patient</span>
Patient muscle biopsies were obtained from diagnosis procedures either from Groupe Hospitalier Pitie-Salpetriere Hospital (Paris, France) or from Children's National Medical Center (Washington DC) according to local ethical committee regulations. All biopsies were flash-frozen in isopentane cooled in liquid nitrogen immediately after excision and were stored in air-tight hydrated containers until use. All muscle samples were tested histologically by cryosection and showed excellent preservation of muscle morphology by hematoxylin-eosin histology. Characteristics of the patient population are provided in Table S1.
###end p 57
###begin title 58
Antibodies and immunostaining
###end title 58
###begin p 59
###xml 137 157 137 157 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib15">Fischer et al., 2001</xref>
###xml 205 223 205 223 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib18">Grady et al., 2005</xref>
###xml 290 308 290 308 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib19">Haque et al., 2006</xref>
###xml 364 383 364 383 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib20">Hodzic et al., 2004</xref>
###xml 385 403 385 403 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib10">Crisp et al., 2006</xref>
###xml 436 455 436 455 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib18">Grady et al. (2005)</xref>
Anti-LAP2, -Nesprin-1, -SUN1 and -SUN2 antibodies were gifts from K. Wilson (Johns Hopkins University School of Medicine, Baltimore, MD; Fischer et al., 2001), J. Sanes (Harvard University, Cambridge, MA; Grady et al., 2005), S. Shackleton (University of Leicester, Leicester, England, UK; Haque et al., 2006), and D. Hodzic (Washington University, St. Louis, MO; Hodzic et al., 2004; Crisp et al., 2006), respectively. As described in Grady et al. (2005), the antibody against Nesprin-1 (Syne-1) recognizes a region that is highly conserved in Nesprin-2 (Syne-2) and could therefore recognize both proteins. The lamin B antibody (Santa Cruz Biotechnology, Inc.) recognized lamin B1 and, to a lesser extent, lamin B2 and B3. Histone acetylation levels were evaluated using acetyl-histone H3-K9 and acetyl-histone H4 antibodies (Millipore). The NMJs were stained using the Alexa Fluor 488 conjugate Bgt (Invitrogen). Muscle fibers were delineated on tissue section using alpha2-laminin antibody, clone 4H8-2 (Sigma-Aldrich), a component of the extracellular lamina.
###end p 59
###begin p 60
###xml 129 148 129 148 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib23">Koenen et al., 2005</xref>
###xml 150 168 150 168 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib29">Mejat et al., 2005</xref>
Immunofluorescence experiments and Bgt staining on diaphragms and isolated muscle fibers were performed as described previously (Koenen et al., 2005; Mejat et al., 2005).
###end p 60
###begin p 61
###xml 1120 1131 1120 1131 <sup xmlns:xlink="http://www.w3.org/1999/xlink">H222P/H222P</sup>
###xml 1116 1131 1116 1131 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Lmna<sup>H222P/H222P</sup></italic>
###xml 1141 1144 1141 1144 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 1137 1144 1137 1144 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Lmna<sup>&#8722;/&#8722;</sup></italic>
Diaphragms were flat-mounted in Vectashield mounting medium containing DAPI (H-1200; Vector Laboratories). Z serial images were collected using a UPlanApo 10x 0.40 objective lens (Olympus) on a microscope (DeltaVision IX70; Olympus) controlled by a Deltavision system (Applied Precision, LLC) and fitted with a charge-coupled device camera (CoolSnap; Photometrics). Image stacks were deconvolved using SoftWoRx 3.5.1 (Applied Precision, LLC) and projected into a single image. Because of the size of the diaphragm, multiple z serial images were taken to cover the whole diaphragm, then the projected images were combined using SoftWoRx 3.5.1 or Photoshop CS3 (Adobe). When necessary, brightness and contrast adjustments were applied to the whole reconstituted image using Photoshop CS3. The width of the innervation area was defined as the distance between the two AChR clusters located at the maximal distance from the main axis of the diaphragm. For each diaphragm, a minimum of 200 measurements regularly spaced along the length of the diaphragm were taken. At least three diaphragms of each genotype (wild type, LmnaH222P/H222P, and Lmna-/-) were quantified using ImageJ (National Institutes of Health).
###end p 61
###begin p 62
###xml 37 42 <span type="species:ncbi:10090">mouse</span>
###xml 510 514 <span type="species:ncbi:9925">goat</span>
###xml 520 526 <span type="species:ncbi:9986">rabbit</span>
###xml 1078 1082 <span type="species:ncbi:10090">mice</span>
For immunofluorescence microscopy on mouse muscle fibers, tibialis anterior muscles were dissected and fixed in 4% PFA/PBS for 30 min at RT, rinsed with PBS, pH 7.5, at RT, and permeabilized and blocked in the blocking buffer (1% BSA/0.5% Triton X-100/PBS) overnight at 4degreesC. They were then incubated overnight at 4degreesC with the primary antibody (1:500) in blocking buffer. Samples were washed three times for 1 h each time in 0.5% Triton X-100/PBS, incubated with secondary antibody (Alexa Fluor 568 goat anti-rabbit, 1:500; Invitrogen) and Bgt-Alexa Fluor conjugate (1:1,000) for 1 h at RT in blocking buffer, and then washed three times for 1 h each time in 0.5% Triton X-100/PBS, plus an overnight incubation at 4degreesC. Finally, isolated fibers were flat-mounted in mounting medium containing DAPI. Z serial images were collected using a PlanApo 100x 1.4 lens (Nikon) on an Eclipse E800 (Nikon), and image stacks were projected into a single image using Metamorph 6.3 software (MDS Analytical Technologies). A minimum of 100 fibers from at least three different mice of each genotype were analyzed for each staining.
###end p 62
###begin p 63
###xml 37 42 <span type="species:ncbi:9606">human</span>
###xml 523 529 <span type="species:ncbi:9793">donkey</span>
###xml 535 538 <span type="species:ncbi:10116">Rat</span>
###xml 563 567 <span type="species:ncbi:9925">goat</span>
###xml 573 579 <span type="species:ncbi:9986">rabbit</span>
For immunofluorescence microscopy on human muscle biopsies, tissue sections were fixed in 4% PFA/PBS for 10 min at RT, rinsed with PBS, pH 7.5, at RT, permeabilized in 1% Triton X-100/PBS for 30 min at RT, and then blocked in 2% BSA in PBS for 30 min at RT. After an overnight incubation at 4degreesC with the primary anti-acetylated histone and anti-alpha2-laminin antibodies (1:200) in blocking buffer, the samples were washed three times in 0.5% Triton X-100 in PBS, incubated with secondary antibodies (Alexa Fluor 488 donkey anti-Rat IgG and Alexa Fluor 568 goat anti-rabbit, 1:500; Invitrogen) for 1 h at RT in blocking buffer, and then washed three times in PBS. Finally, tissue sections were flat-mounted in DAPI-containing mounting media. Z serial images were collected using a PlanApo 20x 0.75 NA lens (Nikon) on an Eclipse E800, and image stacks were projected into a single image using Metamorph 6.3 software. For all imaging, exposure settings were identical between compared samples and genotypes.
###end p 63
###begin title 64
Counting of synaptic and perisynaptic nuclei
###end title 64
###begin p 65
###xml 90 108 90 108 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib18">Grady et al., 2005</xref>
###xml 495 499 <span type="species:ncbi:10090">mice</span>
Quantification of synaptic and perisynaptic nuclei was performed as described previously (Grady et al., 2005). In brief, a nucleus was defined as synaptic when at least 25% of the DAPI and Nesprin-1 or SUN2 signal overlapped with the Bgt-positive site, and a perisynaptic nucleus was defined as one for which the DAPI and Nesprin-1 signal did not overlap with the Bgt-positive site but was less than half its diameter from the edge of a site. A minimum of 100 NMJs from at least three different mice of each genotype were analyzed.
###end p 65
###begin title 66
Real-time quantitative RT-PCR
###end title 66
###begin p 67
###xml 480 485 479 484 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GAPDH</italic>
###xml 764 775 763 774 <sup xmlns:xlink="http://www.w3.org/1999/xlink">H222P/H222P</sup>
###xml 760 775 759 774 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Lmna<sup>H222P/H222P</sup></italic>
###xml 785 788 784 787 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 781 788 780 787 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Lmna<sup>&#8722;/&#8722;</sup></italic>
###xml 272 277 <span type="species:ncbi:10090">mouse</span>
###xml 303 308 <span type="species:ncbi:9606">human</span>
###xml 519 524 <span type="species:ncbi:10090">mouse</span>
###xml 568 573 <span type="species:ncbi:10090">mouse</span>
###xml 658 663 <span type="species:ncbi:10090">mouse</span>
###xml 729 733 <span type="species:ncbi:10090">mice</span>
###xml 791 795 <span type="species:ncbi:10090">Mice</span>
###xml 880 885 <span type="species:ncbi:10090">mouse</span>
###xml 890 895 <span type="species:ncbi:9606">human</span>
Gene expression was evaluated by quantitative RT-PCR (MyiQ; Bio-Rad Laboratories) using the iQ SYBR Green Supermix (Bio-Rad Laboratories) on total RNA extracted (RNA fibrous tissue mini kit; QIAGEN) from homogenized (in RLT buffer; TissueRuptor Homogenizer; QIAGEN) whole mouse gastrocnemius muscles or human tissue sections. 500 mug of total RNA was reverse-transcribed using Superscript III (Invitrogen) according to manufacturer's instructions. All measures were normalized to GAPDH RNA levels. The sequences of the mouse primers are provided in Table S2. For each mouse, the two gastrocnemius muscles were analyzed separately, providing two measures per mouse, and the gene expression levels were evaluated in at least three mice per phenotype (wild type, LmnaH222P/H222P, and Lmna-/-). Mice of a given age were compared with their wild-type littermates. The sequences of the mouse and human primers are provided in Table S2.
###end p 67
###begin title 68
AAV vector construction, viral production, and in vivo administration
###end title 68
###begin p 69
###xml 113 130 113 130 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib52">Wang et al., 2003</xref>
###xml 176 178 175 177 <sup xmlns:xlink="http://www.w3.org/1999/xlink">12</sup>
###xml 72 75 <span type="species:ncbi:12305?0.03296277145811789|species:ncbi:36410?3.8779731127197516E-4">CMV</span>
###xml 202 206 <span type="species:ncbi:10804?0.6129032258064516">AAV2</span>
###xml 318 322 <span type="species:ncbi:10090">mice</span>
The AAV vector containing the GFP reporter gene (dsAAV-cytomegalovirus [CMV]-GFP) has been described previously (Wang et al., 2003). As a preliminary experiment, 50 mul (1 x 1012 viral particles/ml) of AAV2-GFP, AAV6-GFP, AAV7-GFP, or AAV8-GFP was directly injected into the tibialis anterior of 6-wk-old male C57BL/6 mice using a U-100 insulin syringe. Muscles fibers were assessed for GFP expression by fluorescent microscopy 1 wk after injection. At least three muscles per AAV serotype were analyzed. AAV6 was used in future experiments because this serotype showed a high transduction efficiency of muscle fibers (> 90%) and no nonmuscle cell transduction.
###end p 69
###begin p 70
###xml 531 548 531 548 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib53">Wang et al., 2005</xref>
###xml 594 596 593 595 <sup xmlns:xlink="http://www.w3.org/1999/xlink">12</sup>
###xml 266 269 <span type="species:ncbi:12305?0.03296277145811789|species:ncbi:36410?3.8779731127197516E-4">CMV</span>
###xml 298 301 <span type="species:ncbi:12305?0.03296277145811789|species:ncbi:36410?3.8779731127197516E-4">CMV</span>
###xml 714 718 <span type="species:ncbi:10090">mice</span>
###xml 812 816 <span type="species:ncbi:10090">mice</span>
###xml 945 950 <span type="species:ncbi:10090">mouse</span>
AAV6 vectors containing the shRNA gene against EGFP or LMNA were made by cloning the short hairpin oligonucleotides into the plasmid pSilencer-1.0-U6 (Applied Biosystems) using ApaI and EcoRI sites. The U6-shRNA expression cassettes were then subcloned into a dsAAV-CMV-GFP vector by replacing the CMV promoter using KpnI and EagI sites. The 19-mer shRNA target sequence for EGFP was 5'-CGGCCACAAGTTCAGCGTG-3' and the sequence for LMNA was 5'-GGAGCTTGACTTCCAGAAG-3'. Recombinant AAV6 vectors were produced as described previously (Wang et al., 2005). For intramuscular injection, 50 mul (1 x 1012 viral particles/ml) of viral solution was directly injected into the left tibialis anterior of 6-wk-old male C57BL/6 mice using a U-100 insulin syringe. 1-5 wk after injection, for each time point, a minimum of six mice were killed, and their injected muscles were assessed by quantitative RT-PCR, Western blotting, or immunofluorescence. For each mouse, the right contralateral noninjected tibialis anterior was used as control (noninjected).
###end p 70
###begin title 71
Western blot
###end title 71
###begin p 72
###xml 412 416 <span type="species:ncbi:9925">goat</span>
###xml 489 494 <span type="species:ncbi:10090">mouse</span>
###xml 551 557 <span type="species:ncbi:9793">donkey</span>
###xml 563 567 <span type="species:ncbi:9925">goat</span>
###xml 613 619 <span type="species:ncbi:9986">rabbit</span>
###xml 625 630 <span type="species:ncbi:10090">mouse</span>
Frozen tibialis anterior muscles were homogenized in a total protein extraction buffer (2% SDS, 250 mM sucrose, 75 mM urea, 1 mM dithiothreitol, and 50 mM Tris-HCl, pH 7.5) with protease inhibitor (protease inhibitor cocktail III; EMD) by TissueRuptor System (QIAGEN). After determination of protein concentration, equal amounts of total proteins were separated on 7.5% SDS-PAGE gels and hybridized with primary goat lamin A/C antibody (1:1,000; Santa Cruz Biotechnology, Inc.) or primary mouse histone H3 antibody (1:1,000; Abcam) and with secondary donkey anti-goat (1:1,000; Santa Cruz Biotechnology, Inc.) or rabbit anti-mouse IgG HRP-conjugated antibodies (Amersham enhanced chemiluminescence [ECL] Western blot analysis system; GE Healthcare). Recognized proteins were visualized with an ECL Western blot analysis system (GE Healthcare).
###end p 72
###begin title 73
Statistical analysis
###end title 73
###begin p 74
###xml 94 95 94 95 <italic xmlns:xlink="http://www.w3.org/1999/xlink">t</italic>
Statistical analysis was performed with the unpaired, unequal variances, two-tailed Student's t test using Excel software (Microsoft).
###end p 74
###begin title 75
Online supplemental material
###end title 75
###begin p 76
###xml 177 181 177 181 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Lmna</italic>
###xml 264 268 264 268 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LMNA</italic>
###xml 98 102 <span type="species:ncbi:10090">mice</span>
###xml 182 186 <span type="species:ncbi:10090">mice</span>
###xml 303 311 <span type="species:ncbi:9606">patients</span>
Fig. S1 presents SUN1, SUN2, and Nesprin-1 localizations in muscle fibers in wild-type and mutant mice. Fig. S2 shows synaptic nuclei acetylation levels in wild-type and mutant Lmna mice. Fig. S3 presents GFP expression in muscle fibers and transient knockdown of LMNA using AAV. Table S1 describes the patients and normal volunteers included in this study. Table S2 presents the sequences of the primers used in quantitative PCR experiments. Online supplemental material is available at .
###end p 76
###begin title 77
Supplementary Material
###end title 77
###begin title 78
[Supplemental Material Index]
###end title 78
###begin p 79
We wish to thank Gisela Stolstenburg, Emmanuelle Lacene, and Stephanie Bauche for their help with histopathology evaluation of muscle biopsies and Karen Meaburn, Rabah Ben Yaou, and Jeanine Koenig for constructive discussion.
###end p 79
###begin p 80
###xml 450 454 <span type="species:ncbi:9319">Euro</span>
Fluorescence imaging was in part done at the National Cancer Institute (NCI) Fluorescence Imaging Facility. This research was supported by the Intramural Research Program of the National Institutes of Health (NIH), NCI, and Center for Cancer Research; the Institut National de la Sante et de la Recherche Medicale (INSERM), Assistance Publique-Hopitaux de Paris, Association Francaise contre les Myopathies (AFM), the European Union Fifth Framework (Euro-laminopathies contract No. 018690), and the Association Francaise contre les Myopathies (AFM) rare disorder network program (10722).
###end p 80

